,drug_name,section_name,gpt_output
0,KYPROLIS,adverse reactions,"cardiac toxicities, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome (PRES), anemia, fatigue, nausea, pyrexia, decreased lymphocytes, headache, cough, edema peripheral, neutropenia, decreased absolute neutrophil count, decreased phosphorus, decreased total white blood cell count, hypokalemia, diarrhea, muscle spasm, upper respiratory tract infection, constipation, leukopenia, pneumoni,a bronchitis, nasopharyngitis, infections, metabolic disorders, hypocalcemia, hyperglycemia, muscular weakness, myalgia, peripheral neuropathies, insomnia, chills, infusion site reaction, multi-organ failure, pain, febrile neutropenia, lymphopenia, cardiac arrest, cardiac failure congestive, myocardial infarction, myocardial ischemia, cataract, blurred vision, abdominal pain, abdominal pain upper, dyspepsia, toothache, hepatobiliary disorders, hepatic failure, influenza, urinary tract infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, hypomagnesemia, hypophosphatemia, hypoesthesia, paresthesia, anxiety, renal impairment, dysphonia, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, rash, deep vein thrombosis, hypotension, death"
1,KYPROLIS,warnings and precautions,"cardiac failure, myocardial infarction, death, myocardial ischemia, acute renal failure, tumor lysis syndrome, acute respiratory distress syndrome, acute respiratory failure, acute diffuse infiltrative pulmonary disease, pulmonary hypertension, dyspnea, hypertension, hypertensive crisis, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, posterior reversible encephalopathy syndrome, embryo-fetal toxicity."
2,MULTAQ,adverse reactions,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, gastrointestinal disorders, dyspeptic signs and symptoms, asthenic conditions, bradycardia, rashes, generalized rash, macular rash, maculo-papular rash, erythematous rash, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, increases in creatinine, QTc prolonged, cardiac - new or worsening heart failure, atrial flutter with 1:1 atrioventricular conduction, hepatic - liver injury, respiratory - interstitial lung disease, pneumonitis, pulmonary fibrosis, immune - anaphylactic reactions, angioedema, vascular - vasculitis, leukocytoclastic vasculitis."
3,MULTAQ,boxed warnings,"death, stroke, heart failure"
4,MULTAQ,warnings and precautions,"atrial fibrillation (AF), liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, renal impairment, teratogen, cardiovascular death, heart failure, stroke, new onset heart failure, worsening heart failure, hepatocellular liver injury, acute liver failure, interstitial lung disease, pneumonitis, pulmonary fibrosis, QT interval prolongation, pre-renal azotemia, acute renal failure, increase in serum creatinine, death"
5,JUBLIA,adverse reactions,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
6,TEFLARO,adverse reactions,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, hypersensitivity, increase transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis"
7,TEFLARO,warnings and precautions,"serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea, CDAD, fatal colitis, drug-induced hemolytic anemia, development of drug-resistant bacteria, anemia, death"
8,DATSCAN,adverse reactions,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, injection site pain"
9,DATSCAN,warnings and precautions,"hypersensitivity reactions, anaphylactic treatment measures, skin erythema, pruritis, corticosteroids, anti-histamines, thyroid accumulation, thyroid neoplasia"
10,TIVICAY,adverse reactions,"hypersensitivity reactions, effects on serum liver biochemistries, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, attempt, behavior, completion, renal impairment, pruritus, elevated ALT, elevated AST, elevated creatine kinase, hyperglycemia, elevated lipase, neutropenia, death"
11,TIVICAY,warnings and precautions,"hypersensitivity reactions, rash, constitutional findings, organ dysfunction, liver injury, death, transaminase elevations, hepatotoxicity, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response, indolent infections, residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
12,TAFINLAR,adverse reactions,"new primary malignancies, tumor promotion in BRAF wild-type melanoma, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, hyperkeratosis, headache, pyrexia, arthralgia, papilloma, alopecia, palmar-plantar erythrodysesthesia syndrome, chills, fatigue, rash, nausea, vomiting, diarrhea, abdominal pain, peripheral edema, cough, night sweats, decreased appetite, constipation, myalgia, back pain, myalgia, cutaneous squamous cell carcinoma, cuSCC, cough, constipation, nasopharyngitis, hypophosphatemia, increased alkaline phosphatase, hyponatremia, pancreatitis, hypersensitivity manifesting as bullous rash, interstitial nephritis, vision blurred, transient blindness, stomatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased AST, increased alkaline phosphatase, increased ALT, hyperbilirubinemia, hyperglycemia, increased GGT, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation"
13,TAFINLAR,warnings and precautions,"Retinal vein occlusion, Interstitial lung disease, New primary malignancies, Tumor Promotion in BRAF Wild-Type Melanoma, Hemorrhage, Venous Thromboembolism, Cardiomyopathy, Ocular Toxicities, Serious Febrile Reactions, Serious Skin Toxicity, Hyperglycemia, Glucose-6-Phosphate Dehydrogenase Deficiency, Embryofetal Toxicity, Pyrexia, Intracranial hemorrhage, Gastric hemorrhage, Deep vein thrombosis, Pulmonary embolism, Retinal Pigment Epithelial Detachment (RPED), Uveitis, Iritis, Cutaneous squamous cell carcinoma, Keratoacanthoma, Melanoma, Basal cell carcinoma, Hypotension, Rigors, Chills, Dehydration, Renal failure, Hemolytic anemia, death"
14,HORIZANT,adverse reactions,"somnolence/sedation, dizziness, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, asthenia, insomnia, breast enlargement, gynecomastia, elevated creatine kinase"
15,HORIZANT,warnings and precautions,"driving impairment, somnolence, sedation, dizziness, suicidal thoughts or behaviors, fatigue, asthenia, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, fever, rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, eosinophilia, withdrawal seizure, pancreatic acinar cell adenoma, pancreatic acinar cell carcinoma, death"
16,IMBRUVICA,adverse reactions,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, hyperuricemia, pyrexia, asthenia, petechiae, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, stomatitis, dyspepsia, sinusitis, urinary tract infection, chills, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, anxiety, insomnia, hypertension, contusion, vision blurred, pruritus, arthropathy, skin cancer, anaphylactic shock, urticaria, angioedema, death"
17,IMBRUVICA,warnings and precautions,"hemorrhage, bleeding, infections, fever, cytopenias, atrial fibrillation, atrial flutter, second primary malignancies, skin cancers, other carcinomas, tumor lysis syndrome, embryo-fetal toxicity, fetal harm, malformations, reduced fetal weights, subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage, bruising, petechiae, grade 3 or higher bleeding events, fatal bleeding events, progressive multifocal leukoencephalopathy (PML), thrombocytopenia, anemia, neutropenia, non-melanoma skin cancer, death"
18,ULORIC,adverse reactions,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior, aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens Johnson Syndrome, hypersensitivity skin reactions, death"
19,ULORIC,warnings and precautions,"gout flare, cardiovascular thromboembolic events, MI (myocardial infarction), stroke, hepatic failure, fatal hepatic failure, non-fatal hepatic failure, transaminase elevations, liver injury, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice, severe drug-induced liver injury, death"
20,CIMZIA,adverse reactions,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, severe skin reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, psoriasis, sarcoidosis"
21,CIMZIA,boxed warnings,"serious infections, malignancy, hospitalization, death, active tuberculosis, reactivation of latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, opportunistic pathogens, Legionella, Listeria, sepsis, Lymphoma, other malignancies"
22,CIMZIA,warnings and precautions,"serious infections, invasive fungal infections, lymphoma, other malignancies, heart failure, anaphylaxis, serious allergic reactions, hepatitis B virus reactivation, demyelinating disease, cytopenias, pancytopenia, lupus-like syndrome, hospitalization, death, tuberculosis, chronic leukemia, worsening congestive heart failure (CHF), new onset CHF, hypersensitivity reactions, angioedema, dyspnea, hypotension, rash, serum sickness, urticaria, hepatosplenic T-cell lymphoma (HSTCL), acute leukemia, chronic leukemia, skin cancer, central nervous system demyelinating disease, peripheral demyelinating disease, Guillain-Barre syndrome, seizure disorder, optic neuritis, peripheral neuropathy, leukopenia, thrombocytopenia, aplastic anemia, autoantibodies, immunosuppression"
23,KALYDECO,adverse reactions,"Transaminase Elevations, headache, oropharyngeal pain, upper respiratory tract infection, nasal congestion, abdominal pain, nasopharyngitis, diarrhea, rash, nausea, dizziness, hypoglycemia, rhinitis, arthralgia, bacteria in sputum, musculoskeletal chest pain, myalgia, sinus headache, pharyngeal erythema, pleuritic pain, sinus congestion, wheezing, acne"
24,KALYDECO,warnings and precautions,"elevated transaminases, increased transaminase levels, non-congenital lens opacities, cataracts"
25,FULYZAQ,adverse reactions,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
26,FULYZAQ,warnings and precautions,disease may worsen
27,QUTENZA,adverse reactions,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, Nasopharyngitis, Bronchitis, Sinusitis, Nausea, Vomiting, Pruritus, Hypertension, Application site urticaria, Application site paresthesia, Application site dermatitis, Application site hyperesthesia, Application site excoriation, Application site warmth, Application site anesthesia, Application site bruising, Application site inflammation, Application site exfoliation, Peripheral edema, Headache, Burning sensation, Peripheral sensory neuropathy, Dizziness, Dysgeusia, Hyperesthesia, Hypoesthesia, Cough, Throat irritation, Abnormal skin odor"
28,QUTENZA,warnings and precautions,"irritation of eyes or airways, coughing, sneezing, shortness of breath, transient increases in blood pressure, procedural pain, increased blood pressure, treatment-related increases in pain, adverse cardiovascular effects"
29,GRANIX,adverse reactions,"Splenic Rupture, Acute Respiratory Distress Syndrome, Serious Allergic Reactions, Use in Patients with Sickle Cell Disease, Capillary Leak Syndrome, Potential for Tumor Growth Stimulatory Effects on Malignant Cells, Bone Pain, Leukocytosis, Myalgia, Headache, Vomiting, Sweet's Syndrome, Cutaneous Vasculitis, Thrombocytopenia."
30,GRANIX,warnings and precautions,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), Allergic reactions, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome, hypotension, hypoalbuminemia, edema, hemoconcentration, death."
31,COARTEM,adverse reactions,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, pyrexia, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, cough, pruritus, rash, vertigo, malaria, nasopharyngitis, chills, asthenia, fatigue, abdominal pain, diarrhea, nausea, Plasmodium falciparum infection, rhinitis, anorexia, headache, dizziness, splenomegaly, anemia, hepatomegaly, aspartate aminotransferase increased, arthralgia, myalgia, rash, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, malaria, nasopharyngitis, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, serious skin reactions (bullous eruption)"
32,COARTEM,warnings and precautions,"QT prolongation, hypokalemia, hypomagnesemia, symptomatic cardiac arrhythmias, clinically relevant bradycardia, severe cardiac disease, sudden death, decreased exposure to lumefantrine, decreased efficacy, increased risk of adverse effects, reduction in effectiveness of hormonal contraceptives, recrudescence, severe hepatic impairment, severe renal impairment, relapsing malaria"
33,APTIOM,adverse reactions,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, asthenia, rash, dysarthria, diarrhea, constipation, abdominal pain, gastritis, gait disturbance, peripheral edema, Urinary tract infections, Fall, Hyponatremia, balance disorder, memory impairment, nystagmus, depression, insomnia, cough, hypertension, decreases in hemoglobin, decreases in hematocrit, increases in total cholesterol, increases in triglycerides, increases in LDL, increases in creatine phosphokinase"
34,APTIOM,warnings and precautions,"suicidal thoughts, suicidal behavior, depression, unusual changes in mood or behavior, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Anaphylactic Reactions, Angioedema, Hyponatremia, dizziness, disturbance in gait and coordination, somnolence, fatigue, cognitive dysfunction, visual changes, serious nausea/vomiting, dehydration, gait instability, injury, seizures, hypochloremia, ataxia, vertigo, balance disorder, gait disturbance, nystagmus, abnormal coordination, nausea, vomiting, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, diplopia, blurred vision, impaired vision, liver injury, jaundice, elevations in transaminases, elevated bilirubin, abnormal thyroid function tests, decreases in serum T3 and T4, death"
35,PROLIA,adverse reactions,"hypocalcemia, serious infections, dermatologic adverse reactions, osteonecrosis of the jaw, atypical subtrochanteric and diaphyseal femoral fractures, back pain, pain in extremity, musculoskeletal pain, hypercholesterolemia, cystitis, arthralgia, nasopharyngitis, anemia, angina pectoris, atrial fibrillation, vertigo, abdominal pain upper, flatulence, gastroesophageal reflux disease, edema peripheral, asthenia, upper respiratory tract infection, pneumonia, pharyngitis, herpes zoster, bone pain, myalgia, spinal osteoarthritis, sciatica, insomnia, rash, pruritus, pancreatitis, new malignancies, cataracts, drug-related hypersensitivity reactions, anaphylaxis, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, severe musculoskeletal pain, marked elevation in serum PTH, death"
36,PROLIA,warnings and precautions,"hypersensitivity, anaphylactic reactions, hypocalcemia, osteonecrosis of the jaw, atypical femoral fractures, serious infections, skin infections, dermatitis, rashes, eczema, severe bone pain, joint pain, muscle pain, suppression of bone turnover, hypotension, dyspnea, throat tightness, facial edema, upper airway edema, pruritus, urticaria, disturbances of mineral metabolism, marked elevations of serum parathyroid hormone (PTH), infections of the abdomen, urinary tract infections, ear infections, endocarditis, opportunistic infections, dermatologic adverse reactions, incapacitating bone pain, incapacitating joint pain, incapacitating muscle pain, consequences of bone oversuppression"
37,BLINCYTO,adverse reactions,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, pyrexia, headache, peripheral edema, nausea, hypokalemia, tremor, rash, constipation, pneumonia, sepsis, device-related infection, encephalopathy, overdose, confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Increased weight, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, erythema, Hypotension, Hypertension, leukocytosis, lymphopenia, tachycardia, edema, cytokine storm, decreased immunoglobulins, increased blood bilirubin, increased gamma-glutamyl-transferase, tumor lysis syndrome, hypoalbuminemia, paresthesia, aphasia, convulsion, memory impairment, cognitive disorder, speech disorder, confusion, disorientation, capillary leak syndrome, hypersensitivity, bronchospasm, death."
38,BLINCYTO,boxed warnings,"Cytokine Release Syndrome, CRS, life-threatening, fatal, Neurological toxicities, severe, death"
39,BLINCYTO,warnings and precautions,"infections, effects on ability to drive and use machines, preparation and administration errors, cytokine release syndrome (CRS), infusion reactions, pyrexia, headache, nausea, asthenia, hypotension, increased alanine aminotransferase, increased aspartate aminotransferase, increased total bilirubin, disseminated intravascular coagulation (DIC), capillary leak syndrome (CLS), hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS), neurological toxicities, encephalopathy, convulsions, speech disorders, disturbances in consciousness, confusion and disorientation, coordination and balance disorders, sepsis, pneumonia, bacteremia, opportunistic infections, catheter-site infections, tumor lysis syndrome (TLS), neutropenia, febrile neutropenia, elevated liver enzymes, leukoencephalopathy, death"
40,STENDRA,adverse reactions,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, dizziness, arthralgia, diarrhea, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, electrocardiogram abnormal, gastroenteritis viral, color vision changes, non-arteritic anterior ischemic optic neuropathy (NAION), vision loss, death"
41,STENDRA,warnings and precautions,"hypotension, prolonged erection, priapism, penile tissue damage, permanent loss of potency, sudden loss of vision, Non-Arteritic Ischemic Optic Neuropathy (NAION), sudden decrease or loss of hearing, tinnitus, dizziness, lightheadedness, fainting, symptomatic hypotension, headache, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, bleeding disorders, active peptic ulceration, anti-aggregatory effect"
42,XIAFLEX,adverse reactions,"Tendon ruptures, injury to the injected extremity, Corporal rupture (penile fracture), severe penile hematoma, penile ecchymoses, penile detumescence, penile ""popping"" sound or sensation, edema peripheral, contusion, injection site hemorrhage, injection site reaction, pain in the injected extremity, penile swelling, penile pain, pruritus, lymphadenopathy, axillary mass, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, blood blister, injection site hematoma, ecchymosis, penile blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain"
43,XIAFLEX,boxed warnings,"Corporal rupture, Penile fracture, Serious penile injury, Penile ecchymoses, Hematoma, Sudden penile detumescence, Penile ""popping"" sound, Severe penile hematoma, Death"
44,XIAFLEX,warnings and precautions,"tendon rupture, serious injury, injected finger/hand injury, permanent injury, ligament damage, skin laceration, corporal rupture (penile fracture), serious injury to the penis, hypersensitivity reactions, anaphylaxis, abnormal coagulation, pulley rupture, complex regional pain syndrome (CRPS), sensory abnormality of the hand, skin tear, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound or sensation, severe penile hematoma, pruritus, injection site hemorrhage, bleeding, ecchymosis/contusion"
45,XEOMIN,adverse reactions,"hypersensitivity, dysphagia, breathing difficulties, spread of toxin effects, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye disorders, blepharospasm, eye disorder, sensation of pressure, facial pain, facial paresis (brow ptosis), muscle disorder (elevation of eyebrow), injection site swelling, eye swelling, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscle spasm, dysarthria, myalgia, nausea, flu-like symptoms, injection site reaction"
46,XEOMIN,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
47,XEOMIN,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, compromised respiratory function, dysphagia, concomitant neuromuscular disorders, smaller neck muscle mass, corneal exposure, corneal ulceration, reduced blinking, ulceration, perforation, diplopia, ptosis, risk of ptosis, asthenia, generalized muscle weakness, blurred vision, dysphonia, dysarthria, urinary incontinence, breathing difficulties, anaphylaxis, serum sickness, urticaria, soft tissue edema, hypersensitivity reactions, severe dysphagia, aspiration, respiratory failure, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junctional disorders, severe dysphagia and respiratory compromise, ectropion, narrow angle glaucoma, ecchymosis, levator palpebrae superioris, corrugator injections, transmission of viral diseases, Creutzfeldt-Jakob disease (CJD), death"
48,GILOTRIF,adverse reactions,"diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease (ILD), hepatic toxicity, keratitis, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, serious adverse reactions, pulmonary toxicity, sepsis, pneumonia, dyspnea, fatigue, hypokalemia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, cheilitis, cystitis, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, aspartate aminotransferase increased, pancreatitis, death"
49,GILOTRIF,warnings and precautions,"diarrhea, dehydration, renal failure, severe diarrhea, prolonged diarrhea, bullous skin disorders, exfoliative skin disorders, blistering, exfoliating lesions, life-threatening cutaneous reactions, prolonged cutaneous reactions, interstitial lung disease (ILD), lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, hepatic toxicity, fatal hepatic impairment, liver test abnormalities, keratitis, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, embryofetal toxicity, fetal harm, embryotoxic, abortions,death"
50,TREANDA,adverse reactions,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, hypertension, hypertensive crisis, hypersensitivity, nasopharyngitis, infection, herpes simplex, hyperuricemia, pruritus, hemoglobin decreased, platelets decreased, leukocytes decreased, bilirubin elevations, increased AST, increased ALT, creatinine level changes, tachycardia, constipation, abdominal pain, dyspepsia, gastroesophageal reflux disease, abdominal pain upper, abdominal distension, chills, edema peripheral, chest pain, infusion site pain, pain, catheter site pain, herpes zoster, upper respiratory tract infection, urinary tract infection, sinusitis, pneumonia, febrile neutropenia, oral candidiasis, weight decreased, dehydration, decreased appetite, hypokalemia, back pain, arthralgia, pain in extremity, bone pain, headache, dizziness, dysgeusia, insomnia, anxiety, depression, pharyngolaryngeal pain, wheezing, nasal congestion, dry skin, night sweats, hyperhidrosis, hypotension, acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, hemolysis, dysgeusia/taste disorder, atypical pneumonia, sepsis, erythema, dermatitis, skin necrosis, anaphylaxis, phlebitis, pruritus, irritation, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)"
51,TREANDA,warnings and precautions,"myelosuppression, complications of myelosuppression, death, infections, fever, signs of infection, anaphylaxis, infusion reactions, severe anaphylactic reactions, tumor lysis syndrome, acute renal failure, skin reactions, severe skin reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), pre-malignant diseases, malignant diseases, extravasation, embryo-fetal toxicity, neutropenic sepsis, diffuse alveolar hemorrhage, thrombocytopenia, pneumonia, opportunistic infection, CMV, sepsis, septic shock, fever, chills, pruritus, rash, allergic-type reactions, bullous exanthema, erythema, marked swelling, pain, necrosis"
52,CHOLINE,adverse reactions,mild injection site reaction
53,CHOLINE,warnings and precautions,"imaging errors, allergic reactions, anaphylaxis, radiation risk, poor imaging performance, false positive results, false negative results, tissue inflammation, prostatic hyperplasia, interference with imaging, increased risk for cancer"
54,ERWINAZE,adverse reactions,"hypersensitivity reactions, pancreatitis, glucose intolerance, thrombosis, hemorrhage, systemic hypersensitivity, hyperglycemia, transaminases abnormal, fever, local reactions, vomiting, nausea, hyperbilirubinemia, abdominal pain/discomfort, diarrhea, allergy, coagulopathy, infarct, hyperlipidemia, ketoacidosis, CNS events, cerebral venous thrombosis, hepatobiliary disorders, pancreatic disorders, non-hematologic adverse events, non-infectious adverse events, immunogenicity, anti-drug antibodies (ADA), neutralizing antibodies"
55,ERWINAZE,warnings and precautions,"serious hypersensitivity reactions, anaphylaxis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, decreased fibrinogen, decreased protein C activity, decreased protein S activity, decreased anti-thrombin III"
56,TRULICITY,adverse reactions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Documented symptomatic hypoglycemia, Severe hypoglycemia, Heart Rate Increase, Tachycardia, Sinus tachycardia, Immunogenicity, Anti-drug antibodies, Antibodies against native GLP-1, Systemic hypersensitivity, Severe urticaria, Systemic rash, Facial edema, Lip swelling, Injection-site reactions, Injection-site rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular Block, Amylase Increase, Lipase Increase"
57,TRULICITY,boxed warnings,"thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
58,TRULICITY,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Serious Gastrointestinal Disease, Acute renal failure, Worsening of chronic renal failure, Nausea, Vomiting, Diarrhea, Dehydration, Severe abdominal pain, Systemic hypersensitivity reactions, Gastrointestinal adverse reactions, Death"
59,ADREVIEW,adverse reactions,"serious hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising"
60,ADREVIEW,warnings and precautions,"Hypersensitivity reactions, anaphylactic treatment measures, withdrawal signs and symptoms, serious reactions from benzyl alcohol, metabolic acidosis, hypotension, Gasping Syndrome, kernicterus, death, increased radiation exposure, decreased quality of scintigraphic images, false negative imaging results, clinically significant withdrawal symptoms, toxicity, increased long-term risk for thyroid neoplasia, hypertension, transient episode of hypertension"
61,DOTAREM,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, Acute kidney injury, Nausea, Headache, Injection site pain, Injection site coldness, Burning sensation, Feeling cold, Rash, Somnolence, Fatigue, Dizziness, Vomiting, Pruritus, Paresthesia, Dysgeusia, Pain in extremity, Anxiety, Hypertension, Palpitations, Oropharyngeal discomfort, Serum creatinine increased, Site inflammation, Extravasation, Warmth, Bradycardia, Tachycardia, Arrhythmia, Anaphylactoid reactions, Cardiac arrest, Respiratory arrest, Cyanosis, Pharyngeal edema, Laryngospasm, Bronchospasm, Angioedema, Conjunctivitis, Ocular hyperemia, Eyelid edema, Lacrimation increased, Hyperhidrosis, Urticaria, Coma, Convulsion, Syncope, Presyncope, Parosmia, Tremor, Muscle contracture, Muscle weakness, Diarrhea, Salivary hypersecretion, Malaise, Fever, Superficial phlebitis"
62,DOTAREM,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fatal, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, Chronic, severe kidney disease, Acute kidney injury, hypertension, diabetes, reduced renal function, death"
63,DOTAREM,warnings and precautions,"Nephrogenic Systemic Fibrosis, Hypersensitivity, Anaphylactoid reactions, Anaphylactic reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Fibrosis, Rapid decrease in kidney function, Debilitating fibrosis, Serum creatinine levels abnormalities, Acute kidney injury, Circulatory collapse, Tissue irritation, Extravasation, Injection site reactions"
64,PRADAXA,adverse reactions,"bleeding, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, gastritis-like symptoms, GERD, esophagitis, erosive gastritis, gastric hemorrhage, hemorrhagic gastritis, hemorrhagic erosive gastritis, gastrointestinal ulcer, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, fatal bleeding, ICH, non-intracranial fatal bleed, clinically relevant non-major bleeding, myocardial infarction, angioedema, thrombocytopenia, esophageal ulcer, death"
65,PRADAXA,boxed warnings,"thrombotic events, spinal/epidural hematoma, pathological bleeding, paralysis, neurological impairment"
66,PRADAXA,warnings and precautions,"bleeding, serious bleeding, fatal bleeding, death, thrombotic events, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, major bleeding, post-operative pericardial effusions, hemodynamic compromise, spinal hematoma, permanent paralysis, neurological impairment, midline back pain, sensory deficits, motor deficits, numbness, tingling, weakness in lower limbs, bowel dysfunction, bladder dysfunction, spinal cord decompression"
67,ELIQUIS,adverse reactions,"thrombotic events, bleeding, spinal/epidural anesthesia complications, anaphylactic reactions, allergic edema, syncope, death, intracranial bleed, hemorrhagic stroke, gastrointestinal (GI) bleed, fatal bleeding, hypersensitivity reactions, skin rash, hypotension, epistaxis, gastrointestinal hemorrhage, heamtmenesis, melena, hematochezia, liver function test abnormal, blood alkaline phosphatase increased, blood bilirubin increased, hematuria, wound secretion, incision-site hemorrhage, incision-site hematoma, operative hemorrhage, contusions, postoperative hemorrhage, hematoma, vaginal hemorrhage, urethral hemorrhage, postprocedural hemorrhage, postprocedural hematoma, wound hemorrhage, catheter site hemorrhage, vessel puncture site hematoma, anemia, hemorrhagic anemia, nausea, thrombocytopenia, platelet count decreases, increased transaminases, increased alanine aminotransferase, increased aspartate aminotransferase, increased gamma-glutamyltransferase, gingival bleeding, hemoptysis, hypersensitivity, muscle hemorrhage, ocular hemorrhage, conjunctival hemorrhage, rectal hemorrhage, hemorrhagic anemia, hemorrhoidal hemorrhage, anal hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, eye disorders, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma"
68,ELIQUIS,boxed warnings,"thrombotic events, spinal/epidural hematoma, long-term or permanent paralysis"
69,ELIQUIS,warnings and precautions,"serious bleeding, potentially fatal bleeding, blood loss, thrombotic events, stroke, bleeding, pathological bleeding, active pathological hemorrhage, epidural or spinal hematoma, long-term paralysis, permanent paralysis, neurological impairment, numbness, weakness of the legs, bowel dysfunction, bladder dysfunction, death"
70,ZERBAXA,adverse reactions,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, acute renal failure, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, renal and urinary system disorders, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis, death"
71,ZERBAXA,warnings and precautions,"Decreased efficacy, Serious hypersensitivity reactions, anaphylactic reactions, Clostridium difficile-associated diarrhea (CDAD), mild diarrhea, fatal colitis, Development of Drug-Resistant Bacteria, death"
72,FERRIPROX,adverse reactions,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension"
73,FERRIPROX,boxed warnings,"agranulocytosis, neutropenia, serious infections, death"
74,FERRIPROX,warnings and precautions,"infection, fetal harm, agranulocytosis, neutropenia, death, increased ALT values, increased AST values, decreased plasma zinc concentrations"
75,DALVANCE,adverse reactions,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, alanine aminotransferase (ALT) elevations"
76,DALVANCE,warnings and precautions,"serious hypersensitivity, anaphylactic reactions, skin reactions, hypersensitivity, rapid intravenous infusion reactions, ALT elevations, Clostridium difficile-associated diarrhea, CDAD, flushing of the upper body, urticaria, pruritus, rash, Red-Man Syndrome, liver test abnormalities, ALT elevation, AST elevation, bilirubin elevation, diarrhea, fatal colitis, death."
77,ARCAPTA,adverse reactions,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, cough post-inhalation, bronchospasm exacerbation, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
78,ARCAPTA,boxed warnings,"asthma-related death, death"
79,ARCAPTA,warnings and precautions,"acutely deteriorating COPD, cardiovascular effects, fatal, Immediate hypersensitivity reactions, paradoxical bronchospasm, life-threatening, cardiovascular disorders, convulsive disorders, thyrotoxicosis, sensitivity to sympathomimetic drugs, asthma-related death, serious asthma-related events, acute episodes of bronchospasm, excessive use, fatalities, overdoses, allergic reactions, difficulties in breathing, swelling of tongue, lips and face, urticaria, skin rash, increases in pulse rate, systolic or diastolic blood pressure, ECG changes, flattening of the T wave, prolongation of the QTc interval, ST segment depression, coronary insufficiency, cardiac arrhythmias, hypertension, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death."
80,CERDELGA,adverse reactions,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash"
81,CERDELGA,warnings and precautions,"ECG changes, cardiac arrhythmias, prolongation of the PR interval, QTc interval, QRS interval, congestive heart failure, acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia, long QT syndrome"
82,GADAVIST,adverse reactions,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash, Pruritus, Erythema, Hypersensitivity/Anaphylactoid, Dyspnea, Paresthesia, hypotension, urticaria, face edema, eyelid edema, flushing, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
83,GADAVIST,boxed warnings,"nephrogenic systemic fibrosis, NSF, fatal fibrosis, death, debilitating fibrosis, chronic severe kidney disease, acute kidney injury, reduced renal function"
84,GADAVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, Anaphylactic reactions, Hypersensitivity reactions, Cardiovascular manifestations, Respiratory manifestations, Cutaneous manifestations, Death, Acute kidney injury, Dialysis, Extravasation, Moderate irritation, Overestimation of extent of malignant disease"
85,ZYKADIA,adverse reactions,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, ILD/pneumonitis, dyspnea, dehydration, hyperglycemia, nausea, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy, paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy, vision disorder, vision impairment, blurred vision, photopsia, accommodation disorder, presbyopia, reduced visual acuity, prolonged QT interval, bradycardia, Hemoglobin decreased, Alanine transaminase increased, Aspartate transaminase increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin increased, death."
86,ZYKADIA,warnings and precautions,"diarrhea, nausea, vomiting, abdominal pain, hepatotoxicity, Interstitial Lung Disease (ILD), pneumonitis, QT Interval Prolongation, hyperglycemia, bradycardia, pancreatitis, embryofetal toxicity, elevations in alanine aminotransferase (ALT), jaundice, elevations in aspartate aminotransferase (AST), total bilirubin, ventricular tachyarrhythmias, Torsade de pointes, sudden death, CTCAE Grade 3-4 hyperglycemia, glucose intolerance, sinus bradycardia, CTCAE Grade 3-4 elevations of lipase and/or amylase, skeletal anomalies, death"
87,XALKORI,adverse reactions,"hepatotoxicity, interstitial lung disease, pneumonitis, QT interval prolongation, bradycardia, severe visual loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, dyspepsia, dysphagia, abdominal pain, pyrexia, weight increased, pain in extremity, muscle spasm, dizziness, headache, fatigue, neuropathy, gait disturbance, hypoesthesia, muscular weakness, neuralgia, neuropathy peripheral, paresthesia, peripheral sensory neuropathy, polyneuropathy, sensory disturbance, rash, renal cyst, syncope, hypophosphatemia, hematology, neutropenia, lymphopenia, chemistry, ALT elevation, AST elevation, hypokalemia, acute respiratory distress syndrome, arrhythmia, pneumonia, respiratory failure, sepsis, dysesthesia, hypoesthesia, peripheral neuropathy, parasthesia, peripheral sensory neuropathy, burning sensation in skin, hepatic failure"
88,XALKORI,warnings and precautions,"hepatotoxicity, fatal hepatotoxicity, death, Interstitial Lung Disease (ILD), Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, Embryofetal Toxicity, concurrent elevations in alanine aminotransferase (ALT), concurrent elevations in aspartate aminotransferase (AST), transaminase elevations, severe, life-threatening ILD, fatal ILD, QTcF greater than or equal to 500 ms, increase from baseline QTcF greater than or equal to 60 ms, Torsade de pointes, polymorphic ventricular tachycardia, symptomatic bradycardia, heart rate less than 50 beats per minute, Grade 3 syncope, optic atrophy, optic nerve disorder, embryotoxicity, fetotoxicity"
89,BEPREVE,adverse reactions,"mild taste, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, swelling of tongue, swelling of throat"
90,BEPREVE,warnings and precautions,"contamination, contact lens-related irritation"
91,EDARBI,adverse reactions,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, high platelet counts, high WBC counts, rash, pruritus, angioedema"
92,EDARBI,boxed warnings,"fetal toxicity, injury, death"
93,EDARBI,warnings and precautions,"fetal toxicity, fetal renal function reduction, fetal and neonatal morbidity, death, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension, renal failure, symptomatic hypotension, oliguria, progressive azotemia, acute renal failure, increases in serum creatinine, increases in blood urea nitrogen"
94,POTIGA,adverse reactions,"Retinal abnormalities, potential vision loss, Urinary retention, Skin discoloration, Neuropsychiatric symptoms, Dizziness, Somnolence, QT interval effect, Suicidal behavior, ideation, Withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, Nausea, Constipation, Dyspepsia, Influenza, Weight increased, Paresthesia, Amnesia, Dysphasia, Confusional state, Anxiety, Disorientation, Psychotic disorder, Dysuria, Urinary hesitation, Hematuria, Chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, urinary retention, malaise, increased liver enzymes, weight gain, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy, death"
95,POTIGA,boxed warnings,"retinal abnormalities, potential vision loss, damage to the photoreceptors, vision loss, abnormal visual acuity, decreased visual acuity, retinal pigmentary abnormalities, vision changes"
96,POTIGA,warnings and precautions,"urinary retention, skin discoloration, confusional state, psychotic symptoms, hallucinations, dizziness, somnolence, QT prolongation, suicidal thoughts or behaviors, retinal abnormalities, potential vision loss, vision changes, perivascular pigmentation, retinal pigment epithelium clumping, abnormal visual acuity, retinal dystrophy, electroretinogram abnormalities, electrooculogram abnormalities, abnormal fluorescein angiography, diminished sensitivity on visual field testing, urinary hesitation, dysuria, hydronephrosis, renal function impairment, blue skin, grey-blue skin, brown skin, widespread discoloration, facial discoloration, leg discoloration, discoloration of the palate, scleral discoloration, conjunctival discoloration, nail bed discoloration, lips discoloration, mucous membrane discoloration, psychosis, withdrawal seizures"
97,TUDORZA,adverse reactions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, anaphylaxis, angioedema, swelling of the lips, swelling of the tongue, swelling of the throat, urticaria, rash, bronchospasm, itching, death"
98,TUDORZA,warnings and precautions,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, angioedema, anaphylaxis, urticaria, rash, bronchospasm, itching, eye pain, discomfort, blurred vision, visual halos, colored images, red eyes, conjunctival congestion, corneal edema, difficulty passing urine, painful urination"
99,PROMACTA,adverse reactions,"Hepatic Decompensation, Hepatotoxicity, Thrombotic/Thromboembolic Complications, Cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, Vitamin D deficiency, muscle spasms, dyspnea, dizziness, febrile neutropenia, ecchymosis, arthralgia, rhinorrhea, pain in extremity, thrombotic microangiopathy with acute renal failure."
100,PROMACTA,boxed warnings,hepatic decompensation
101,PROMACTA,warnings and precautions,"hepatotoxicity, liver function abnormalities, elevated ALT, elevated AST, elevated bilirubin, indirect hyperbilirubinemia, hepatic decompensation, ascites, encephalopathy, thrombotic complications, thromboembolic complications, venous events, arterial events, portal vein thrombosis (PVT), abdominal pain, nausea, vomiting, diarrhea, cataracts."
102,INLYTA,adverse reactions,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS (reversible posterior leukoencephalopathy syndrome), proteinuria, elevation of liver enzymes, hepatic impairment, fetal development, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia syndrome, hand-foot syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion, retinal thrombosis, polycythemia, transient ischemic attack"
103,INLYTA,warnings and precautions,"hypertension, hypertensive crisis, arterial thrombotic events, venous thrombotic events, hemorrhagic events, cardiac failure, gastrointestinal perforation, fistula, hypothyroidism, thyroid hormone replacement, reversible posterior leukoencephalopathy syndrome (RPLS), proteinuria, liver enzyme elevation, elevation of liver enzymes, fetal harm, death"
104,NORTHERA,adverse reactions,"supine hypertension, hyperpyrexia, confusion, ischemic heart disease, arrhythmias, congestive heart failure, headache, dizziness, nausea, hypertension, fatigue, increased blood pressure, falls, urinary tract infections, syncope"
105,NORTHERA,boxed warnings,supine hypertension
106,NORTHERA,warnings and precautions,"supine hypertension, cardiovascular risk, hyperpyrexia, confusion, exacerbation of ischemic heart disease, arrhythmias, congestive heart failure, allergic reactions, bronchial asthma, neuroleptic malignant syndrome (NMS), fever, hyperthermia, muscle rigidity, involuntary movements, altered consciousness, mental status changes, allergic-type reactions, aspirin hypersensitivity, death"
107,JARDIANCE,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased low-density lipoprotein cholesterol (LDL-C), urinary tract infection, female genital mycotic infections, upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, male genital mycotic infections, nausea, thirst, volume depletion, dehydration, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increased, estimated glomerular filtration rate (eGFR) decreased, blood pressure (ambulatory) decreased, blood pressure systolic decreased, hypovolemia, hemoglobin A1c (HbA1c) increased, phimosis, asymptomatic bacteriuria, cystitis, vaginal mycotic infection, vulvovaginal candidiasis, vulvitis, balanoposthitis, balanitis, scrotal abscess, penile infection, genital infection fungal, genitourinary tract infection, cervicitis, urogenital infection fungal, vaginitis bacterial, increase in hematocrit."
108,JARDIANCE,warnings and precautions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased LDL-C"
109,FANAPT,adverse reactions,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, abdominal discomfort, nausea, diarrhea, nasopharyngitis, upper respiratory tract infection, vision blurred, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, akathisia, bradykinesia, dyskinesia, dystonia, parkinsonism, palpitations, arrhythmia, atrioventricular block first degree, cardiac failure, vertigo, tinnitus, hypothyroidism, conjunctivitis, dry eye, blepharitis, eyelid edema, eye swelling, lenticular opacities, cataract, hyperemia, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, hemoglobin decreased, neutrophil count increased, hematocrit decreased, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, anemia, iron deficiency anemia, leukopenia, retrograde ejaculation"
110,FANAPT,boxed warnings,"increased mortality, death, cardiovascular events, heart failure, sudden death, infectious events, pneumonia"
111,FANAPT,warnings and precautions,"death, cerebrovascular-related adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome (NMS), Tardive dyskinesia, Hyperglycemia, diabetes mellitus, polydipsia, polyuria, polyphagia, weakness, Dyslipidemia, Weight Gain, Seizures, Orthostatic hypotension, Dizziness, tachycardia, syncope, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive impairment, motor impairment, hyperpyrexia, muscle rigidity, altered mental status, autonomic instability, irregular pulse, blood pressure changes, diaphoresis, cardiac dysrhythmia, creatine phosphokinase elevation, myoglobinuria (rhabdomyolysis), acute renal failure, hypokalemia, hypomagnesemia, bradycardia, myocardial infarction, heart failure, drug fever, CNS pathology, galactorrhea, amenorrhea, gynecomastia, impotence, bone density decrease, high cholesterol, high LDL, low HDL, high triglycerides, body temperature dysregulation, Dysphagia, somnolence, sedation."
112,TANZEUM,adverse reactions,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Upper respiratory tract infection, Diarrhea, Nausea, Injection site reaction, Cough, Back pain, Arthralgia, Sinusitis, Influenza, Vomiting, Gastroesophageal reflux disease, Dyspepsia, Constipation, Injection site hematoma, Injection site erythema, Injection site rash, Injection site hypersensitivity, Injection site hemorrhage, Injection site pruritus, Pneumonia, Atrial fibrillation, Atrial flutter, Appendicitis, Immunogenicity, Liver Enzyme Abnormalities, Alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
113,TANZEUM,boxed warnings,"thyroid C-cell tumors, medullary thyroid carcinoma (MTC), mass in the neck, dysphagia, dyspnea, persistent hoarseness"
114,TANZEUM,warnings and precautions,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity Reactions, Renal Impairment, Macrovascular Outcomes, Carcinogenicity of albiglutide, dose-related thyroid C-cell tumors, adenomas, carcinomas, medullary thyroid carcinoma (MTC), persistent severe abdominal pain, vomiting, pruritus, rash, dyspnea, acute renal failure, worsening of chronic renal failure, dehydration, nausea, vomiting, diarrhea, dysphagia, persistent hoarseness, elevated serum calcitonin, death."
115,EYLEA,adverse reactions,"endophthalmitis, retinal detachments, increased intraocular pressure, thromboembolic events, conjunctival hemorrhage, eye pain, cataract, vitreous floaters, vitreous detachment, ocular hyperemia, corneal epithelium defect, detachment of the retinal pigment epithelium, injection site pain, foreign body sensation in eyes, lacrimation increased, vision blurred, intraocular inflammation, retinal pigment epithelium tear, injection site hemorrhage, eyelid edema, corneal edema, hypersensitivity, retinal detachment, retinal tear, death"
116,EYLEA,warnings and precautions,"endophthalmitis, retinal detachments, increases in intraocular pressure, arterial thromboembolic events, nonfatal stroke, nonfatal myocardial infarction, vascular death, death"
117,JEVTANA,adverse reactions,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, death, infections, ventricular fibrillation, cerebral hemorrhage, febrile neutropenia, Arrhythmia, Dyspepsia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, sepsis, septic shock, Hematuria, increased AST, increased ALT, increased bilirubin, fatigue, pyrexia, dizziness, urinary tract infection, dehydration, Gastritis, intestinal obstruction"
118,JEVTANA,boxed warnings,"neutropenia, hypersensitivity, neutropenic deaths, generalized rash/erythema, hypotension, bronchospasm, severe hypersensitivity reactions, death"
119,JEVTANA,warnings and precautions,"bone marrow suppression, neutropenia, febrile neutropenia, neutropenic infections, anemia, thrombocytopenia, pancytopenia, neutropenic deaths, fatal infectious adverse events, sepsis, septic shock, hypersensitivity reactions, generalized rash/erythema, hypotension, bronchospasm, hypersensitivity, nausea, vomiting, diarrhea, mortality related to diarrhea, electrolyte imbalance, gastrointestinal hemorrhage, perforation, ileus, enterocolitis, neutropenic enterocolitis, GI bleeding, abdominal pain, fever, persistent constipation, renal failure, fatal outcomes due to renal failure, embryo-fetal toxicity, embryotoxic, fetotoxic, abortifacient, death"
120,YERVOY,adverse reactions,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, enterocolitis, hepatotoxicity, dermatitis, neuropathy, endocrinopathy, hypopituitarism, adrenal insufficiency, pneumonitis, meningitis, nephritis, eosinophilia, pericarditis, urticaria, large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), death"
121,YERVOY,boxed warnings,"enterocolitis, hepatitis, dermatitis, toxic epidermal necrolysis, neuropathy, endocrinopathy, death"
122,YERVOY,warnings and precautions,"severe immune-mediated reactions, fatal immune-mediated reactions, severe reactions, moderate immune-mediated adverse reactions, immune-mediated hepatitis, immune-mediated endocrinopathies, severe life-threatening immune-mediated enterocolitis, fatal immune-mediated enterocolitis, moderate enterocolitis, intestinal perforation, complications, severe enterocolitis, hospitalization for severe enterocolitis, severe life-threatening immune-mediated dermatitis, fatal immune-mediated dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, severe dermatitis, moderate dermatitis, severe life-threatening hepatotoxicity, fatal hepatic failure, moderate hepatotoxicity, liver function test abnormalities, Grade 3 increases in transaminases, severe immune-mediated neuropathies, fatal Guillain-Barre syndrome, severe peripheral motor neuropathy, myasthenia gravis, Guillain-Barre syndrome, severe life-threatening immune-mediated endocrinopathies, hospitalization for severe endocrinopathies, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, moderate endocrinopathy, hyperthyroidism, Cushing's syndrome, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy (encephalitis), myositis, polymyositis, ocular myositis, severe immune-mediated adverse reactions, uveitis, iritis, episcleritis, immune-mediated ocular disease, death"
123,FARXIGA,adverse reactions,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, increases in low-density lipoprotein cholesterol (LDL-C), bladder cancer, nasopharyngitis, urinary tract infections, back pain, increased urination, male genital mycotic infections, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion (including dehydration, hypovolemia, orthostatic hypotension), renal failure, blood creatinine increase, bone fractures, hypersensitivity reactions (including angioedema, urticaria, hypersensitivity, serious anaphylactic reactions, severe cutaneous adverse reactions), increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol (LDL cholesterol)."
124,FARXIGA,warnings and precautions,"hypotension, volume contraction, symptomatic hypotension, increased serum creatinine, decreased eGFR, renal function impairment, hypoglycemia, genital mycotic infections, increased LDL-C, bladder cancer, hematuria"
125,PICATO,adverse reactions,"local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn"
126,PICATO,warnings and precautions,"severe eye pain, chemical conjunctivitis, corneal burn, eyelid edema, eyelid ptosis, periorbital edema, local skin reactions, vesiculation/pustulation, erosion/ulceration, erythema, crusting, swelling, hypersensitivity reactions, anaphylaxis, allergic contact dermatitis"
127,PRISTIQ,adverse reactions,"Hypersensitivity, Suicidal Thoughts and Behaviors in Adolescents and Young Adults, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, headache, vomiting, fatigue, chills, feeling jittery, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, convulsion, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, ischemic cardiac adverse reactions, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, lipid abnormalities, proteinuria, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome, death"
128,PRISTIQ,boxed warnings,"suicidal thoughts, behaviors, worsening, emergence of suicidal thoughts and behaviors"
129,PRISTIQ,warnings and precautions,"clinical worsening, suicide risk, Serotonin Syndrome, elevated blood pressure, hypertension, abnormal bleeding, angle closure glaucoma, activation of mania/hypomania, discontinuation syndrome, seizure, hyponatremia, interstitial lung disease, eosinophilic pneumonia, suicidality, unusual changes in behavior, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, mental status changes, autonomic instability, tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia, neuromuscular symptoms, tremor, rigidity, myoclonus, hyperreflexia, incoordination, seizures, gastrointestinal symptoms, nausea, vomiting, diarrhea, bleeding events, ecchymosis, hematoma, epistaxis, petechiae, hemorrhages, dizziness, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, hyperhidrosis, dysphoric mood, sensory disturbances, paresthesia, confusion, lethargy, emotional lability, tinnitus, progressive dyspnea, cough, chest discomfort, death"
130,STRIBILD,adverse reactions,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, Ocular icterus, Flatulence, Fatigue, Jaundice, Somnolence, Headache, Dizziness, Insomnia, Abnormal dreams, Rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, anxiety, increased cough, rhinitis, hyperpigmentation, AST elevation, ALT elevation, Amylase elevation, Creatine Kinase elevation, Hematuria, Bone Mineral Density (BMD) decrease, bone fractures, Proteinuria, serum creatinine increase, estimated creatinine clearance decrease, ALT abnormality, alkaline phosphatase abnormality, bilirubin abnormality, serum glucose abnormality, glycosuria, neutrophil abnormality, fasting cholesterol abnormality, fasting triglyceride abnormality, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, increased amylase, hepatic steatosis, hepatitis, increased liver enzymes, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, polyuria, asthenia, death."
131,STRIBILD,boxed warnings,"lactic acidosis, severe hepatomegaly with steatosis, death, severe acute exacerbations of hepatitis B"
132,STRIBILD,warnings and precautions,"acute renal failure, Fanconi syndrome, renal impairment, lactic acidosis, severe hepatomegaly with steatosis, death, pronounced hepatotoxicity, hepatomegaly, steatosis, severe acute exacerbations of hepatitis B, liver decompensation, liver failure, proximal renal tubulopathy, decreased bone mineral density, osteoporosis, bone loss, redistribution/accumulation of body fat, immune reconstitution syndrome, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome"
133,NULOJIX,adverse reactions,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, non-CNS PTLD, EBV seropositive, EBV seronegative, CNS involvement, EBV serostatus unknown, CMV seronegative, CMV seropositive, non-melanoma skin cancer, death, bacterial infections, mycobacterial infections, viral infections, fungal infections, tuberculosis, herpes infections, cryptococcal meningitis, Chagas encephalitis, cerebral aspergillosis, West Nile encephalitis, anaphylaxis, drug hypersensitivity, hypotension, proteinuria, immunogenicity, modified CTLA-4, neutralizing antibodies, new-onset diabetes after transplantation (NODAT), dyslipidemia, total cholesterol, HDL, LDL, triglycerides, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, dyslipidemia, hyperglycemia, hypocalcemia, hypercholesterolemia, hypomagnesemia, hyperuricemia, hematuria, dysuria, renal tubular necrosis, hypotension, dyspnea, blood creatinine increased, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, wound dehiscence, arteriovenous fistula thrombosis, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation"
134,NULOJIX,boxed warnings,"post-transplant lymphoproliferative disorder, central nervous system involvement, malignancies, serious infections, susceptibility to infection, graft loss, death"
135,NULOJIX,warnings and precautions,"Post-Transplant Lymphoproliferative Disorder (PTLD), increased risk, neurological signs and symptoms, cognitive signs and symptoms, behavioral signs and symptoms, Other malignancies, intensity and duration of use, Progressive Multifocal Leukoencephalopathy (PML), neurological signs and symptoms, cognitive signs and symptoms, behavioral signs and symptoms, serious infections, bacterial infections, viral infections, fungal infections, protozoal infections, opportunistic infections, tuberculosis, fatal infections, Polyoma virus-associated nephropathy, kidney graft loss, cytomegalovirus, Cytomegalovirus disease, pneumocystis, Liver transplant (use not recommended), Acute Rejection, Graft Loss, Corticosteroid Minimization, Immunizations, live vaccines, Epstein-Barr virus serology, EBV seronegative, T-cell-depleting therapy, acute rejection, CMV prophylaxis, PML brain imaging, cerebrospinal fluid testing, JC viral DNA, polymerase chain reaction (PCR), brain biopsy, reduction or withdrawal of immunosuppression, cytomegalovirus (CMV), herpes, Pneumocystis jiroveci, Tuberculosis, latent tuberculosis infection, Polyoma Virus Nephropathy (PVAN), BK virus infection, renal function and kidney graft loss, basiliximab induction, acute rejection, particularly Grade III rejection, HLA mismatches, death."
136,LUMIZYME,adverse reactions,"hypersensitivity reactions, anaphylaxis, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, angioedema, throat tightness, supraventricular tachycardia, paresthesia, local swelling, diarrhea, pruritus, edema peripheral, rash papular, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, hyperparathyroidism, proteinuria, nephrotic syndrome, membranous glomerulonephritis, necrotizing skin lesions, death."
137,LUMIZYME,boxed warnings,"anaphylaxis, hypersensitivity, immune-mediated reactions, cardiorespiratory failure, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, tongue swelling, lip swelling, periorbital edema, face edema, urticaria, proteinuria, nephrotic syndrome, necrotizing skin lesions, fluid overload"
138,LUMIZYME,warnings and precautions,"anaphylaxis, hypersensitivity reactions, immune-mediated reactions, acute cardiorespiratory failure, risk of cardiac arrhythmia, sudden cardiac death, ventricular arrhythmias, bradycardia, cardiac arrest, death, respiratory arrest, respiratory distress, hypoxia, apnea, dyspnea, bradycardia, tachycardia, bronchospasm, throat tightness, hypotension, angioedema, urticaria, chest discomfort/pain, wheezing, tachypnea, cyanosis, decreased oxygen saturation, convulsions, pruritus, rash, hyperhidrosis, nausea, dizziness, hypertension/increased blood pressure, flushing/feeling hot, erythema, pyrexia, pallor, peripheral coldness, restlessness, nervousness, headache, back pain, paresthesia, necrotizing skin lesions, inflammatory arthropathy, pyrexia, elevated erythrocyte sedimentation rate, nephrotic syndrome, membranous glomerulonephritis, immune complex deposition"
139,EOVIST,adverse reactions,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, blood pressure increased, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus, rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, elevation of serum iron values, serum bilirubin laboratory values, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness"
140,EOVIST,boxed warnings,"Nephrogenic Systemic Fibrosis (NSF), fibrosis affecting the skin, fibrosis affecting the muscle, fibrosis affecting internal organs, death, Chronic, severe kidney disease, Acute kidney injury."
141,EOVIST,warnings and precautions,"Nephrogenic Systemic Fibrosis, impaired elimination of GBCAs, higher than recommended dosing, repeated dosing, Hypersensitivity, anaphylactoid reactions, hypersensitivity reactions, cardiovascular manifestations, respiratory manifestations, cutaneous manifestations, severe reactions, shock, acute kidney injury, surgery, severe infection, injury, drug-induced kidney toxicity, rapid decrease in kidney function, chronic, severe kidney disease, chronic, moderate kidney disease, chronic, mild kidney disease, debilitating fibrosis, skin fibrosis, muscle fibrosis, internal organ fibrosis, acute kidney injury, chronic renal impairment, dialysis, Extravasation, Injection Site Reactions, myocyte necrosis, inflammation, Serum iron determination, falsely high values, falsely low values, impaired EOVIST imaging performance, severe renal failure, hepatic failure, reduced hepatic contrast, elevated serum ferritin levels, high serum bilirubin, reduced hepatic contrast, death"
142,BELEODAQ,adverse reactions,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, Nausea, Fatigue, Pyrexia, Anemia, Vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal Pain, Hypotension, Phlebitis, Dizziness, Pneumonia, Increased Creatinine, Multi-organ Failure, Febrile Neutropenia, Death"
143,BELEODAQ,warnings and precautions,"thrombocytopenia, leukopenia, neutropenia, lymphopenia, anemia, infection, serious infections, fatal infections, pneumonia, sepsis, hepatotoxicity, liver function test abnormalities, tumor lysis syndrome, nausea, vomiting, diarrhea, embryo-fetal toxicity, teratogenicity, embryo-fetal lethality, death"
144,VICTRELIS,adverse reactions,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, diarrhea, vomiting, dry mouth, chills, asthenia, decreased appetite, arthralgia, dizziness, insomnia, irritability, dyspnea exertional, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, angioedema, urticaria, agranulocytosis, thrombocytopenia, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma"
145,VICTRELIS,warnings and precautions,"birth defects, fetal death, death, anemia, neutropenia, hypersensitivity, urticaria, angioedema, dyspnea, exertional dyspnea, dizziness, syncope, thromboembolic events, pulmonary embolism, acute myocardial infarction, cerebrovascular accident, deep vein thrombosis, pancytopenia"
146,VIMIZIM,adverse reactions,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, immunogenicity, anti-drug antibodies, neutralizing antibodies"
147,VIMIZIM,boxed warnings,"anaphylaxis, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, acute respiratory illness, hypersensitivity reactions, serious acute exacerbation of respiratory compromise"
148,VIMIZIM,warnings and precautions,"anaphylaxis, hypersensitivity reactions, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, nausea, abdominal pain, retching, vomiting, peripheral edema, acute respiratory complications, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis of limbs, urinary incontinence, fecal incontinence, death"
149,SIRTURO,adverse reactions,"increased mortality, death, QT Prolongation, hepatotoxicity, drug interactions, nausea, arthralgia, headache, hemoptysis, chest pain, anorexia, transaminases increased, rash, blood amylase increased"
150,SIRTURO,boxed warnings,"Increased mortality, QT prolongation, ventricular arrhythmia, death"
151,SIRTURO,warnings and precautions,"QT prolongation, significant ventricular arrhythmia, QTcF interval > 500 ms, Hepatotoxicity, liver injury, Increased Mortality, death, ventricular arrhythmias, myocardial infarction, Torsade de Pointes, congenital long QT syndrome, hypothyroidism, bradyarrhythmias, uncompensated heart failure, serum calcium deficiency, magnesium deficiency, potassium deficiency, Clinically significant ventricular arrhythmia, syncope, hepatic-related adverse reactions, alcohol-related liver issues, hepatotoxic drug reactions, fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly, ALT elevation, AST elevation, alkaline phosphatase elevation, bilirubin elevation, aminotransferase elevations"
152,NEURACEQ,adverse reactions,"erythema, irritation, pain"
153,NEURACEQ,warnings and precautions,"Image interpretation errors, false positives, cumulative radiation exposure, image misinterpretation, brain atrophy, motion artifacts, increased risk of cancer, unintentional radiation exposure."
154,COMETRIQ,adverse reactions,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, pneumonia, septicemia, cardiac arrest, respiratory failure, unspecified death, hypocalcemia, increased lipase, pancreatitis, tracheal fistula formation, vomiting, increased thyroid stimulating hormone (TSH), dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, hypomagnesemia, hypokalemia, hyponatremia, death."
155,COMETRIQ,boxed warnings,"perforations, fistulas, gastrointestinal perforations, fistula formation, hemorrhage, severe hemorrhage, fatal hemorrhage, hemoptysis, gastrointestinal hemorrhage, death"
156,COMETRIQ,warnings and precautions,"myocardial infarction, cerebral infarction, arterial thromboembolic events, wound dehiscence, complications requiring medical intervention, hypertensive crisis, osteonecrosis of the jaw, osteomyelitis, osteitis, bone erosion, tooth or periodontal infection, toothache, gingival ulceration, jaw pain, slow healing of the mouth or jaw, Palmar-plantar erythrodysesthesia syndrome (PPES), proteinuria, nephrotic syndrome, reversible posterior leukoencephalopathy syndrome (RPLS), seizures, headache, visual disturbances, confusion, altered mental function, embryofetal toxicity, fetal harm, skeletal variations, visceral variations, malformations, hemorrhage, hemoptysis, venous thromboembolism, arterial thromboembolism, wound healing complications, treatment-emergent hypertension, high blood pressure, Gastrointestinal (GI) perforations, fistulas, tracheal/esophageal fistulas, death."
157,AFINITOR,adverse reactions,"Non-infectious pneumonitis, Infections, Angioedema, Oral ulceration, Renal failure, Impaired wound healing, Stomatitis, Rash, Fatigue, Diarrhea, Edema, Abdominal pain, Nausea, Fever, Asthenia, Cough, Headache, Decreased appetite, Hemoglobin decreased, White blood cell (WBC) decreased, Platelets decreased, Lymphocytes decreased, Neutrophils decreased, Glucose increased, Cholesterol increased, Aspartate transaminase (AST) increased, Alanine transaminase (ALT) increased, Triglycerides increased, Albumin decreased, Potassium decreased, Creatinine increased, Hyperglycemia, Lymphopenia, Anemia, Hypophosphatemia, Increased alkaline phosphatase, Neutropenia, Increased AST, Potassium decreased, Thrombocytopenia, Acute renal failure, Acute respiratory distress, Cardiac arrest, Death (cause unknown), Hepatic failure, Pneumonia, Sepsis, Hepatitis C, Thrombotic events, Pulmonary embolus, Thrombosis, Arthralgia, Back pain, Pain in extremity, Dysgeusia, Insomnia, Dyspnea, Epistaxis, Pleural effusion, Pharyngolaryngeal pain, Rhinorrhea, Hand-foot syndrome (Palmar-plantar erythrodysesthesia syndrome), Nail disorder, Erythema, Onychoclasis, Skin lesion, Acneiform dermatitis, Angioedema, Exacerbation of pre-existing diabetes mellitus, New onset diabetes mellitus, Insomnia, Dizziness, Paresthesia, Eyelid edema, Conjunctivitis, Hypertension, Deep vein thrombosis, Renal failure, Congestive cardiac failure, Jaw pain, Hemorrhage, Amenorrhea, Menorrhagia, Menstrual irregularities, Vaginal hemorrhage, Epistaxis, Otitis media, Depression, Abnormal taste, Increased blood luteinizing hormone (LH) levels, Increased blood follicle stimulating hormone (FSH) levels, Hypersensitivity, Ovarian cyst, Pneumonitis, Angioedema, Hypercholesterolemia, Hypertriglyceridemia, Hypophosphatemia, Increased alkaline phosphatase, Elevated aspartate transaminase (AST), Elevated alanine transaminase (ALT), Fasting hyperglycemia, Pyrexia, Gastroenteritis, Agitation, Rash, Acne, Elevated partial thromboplastin time, Neutropenia, Hypertriglyceridemia, Hypophosphatemia, Hyperglycemia, Elevated creatinine, Cellulitis, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy, death."
158,AFINITOR,warnings and precautions,"non-infectious pneumonitis, death, increased risk of infections, death, angioedema, oral ulceration, mouth ulcers, stomatitis, oral mucositis, renal failure, acute renal failure, death, impaired wound healing, wound-related complications, wound dehiscence, wound infection, incisional hernia, lymphocele, seroma, elevations of serum creatinine, urinary protein, blood glucose, lipids, decreases in hemoglobin, neutrophils, platelets, avoid live vaccines, embryo-fetal toxicity, fetal harm, pneumocystis jiroveci pneumonia (PJP), bacterial infections, fungal infections, viral infections, protozoal infections, pneumonia, mycobacterial infections, aspergillosis, candidiasis, hepatitis B virus reactivation, sepsis, respiratory failure, hepatic failure, hypoxia, pleural effusion, cough, dyspnea, opportunistic infections, hyperglycemia, hyperlipidemia, hypertriglyceridemia, decreased hemoglobin, lymphocytes, neutrophils, platelets, drug-drug interactions, hepatic impairment"
159,BREO,adverse reactions,"asthma-related death, asthma-related hospitalization, Candida albicans infection, increased risk of pneumonia in COPD, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, oropharyngeal candidiasis, candidiasis, fungal oropharyngitis, infections and infestations, nervous system disorders, cough, oropharyngeal pain, dysphonia, back pain, pneumonia, bronchitis, sinusitis, arthralgia, influenza, pharyngitis, pyrexia, viral respiratory tract infection, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, hypersensitivity reactions, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, death"
160,BREO,boxed warnings,"asthma-related death, increased risk of asthma-related hospitalization, death"
161,BREO,warnings and precautions,"asthma-related death, asthma-related hospitalizations, overdose, Candida albicans infection, pneumonia, worsening of infections, tuberculosis, fungal infections, bacterial infections, viral infections, parasitic infections, ocular herpes simplex, chickenpox, measles, impaired adrenal function, hypercorticism, adrenal suppression, paradoxical bronchospasm, cardiovascular disorders, decrease in bone mineral density, glaucoma, cataracts, convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, death"
162,FIRAZYR,adverse reactions,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache"
163,FIRAZYR,warnings and precautions,"laryngeal attacks, airway obstruction, death"
164,INVOKANA,adverse reactions,"Hypotension, Impairment in Renal Function, Hyperkalemia, Hypoglycemia, Genital Mycotic Infections, Hypersensitivity Reactions, Bone Fracture, Increases in Low-Density Lipoprotein (LDL-C), Female genital mycotic infections, Urinary tract infections, Increased urination, Male genital mycotic infections, Vulvovaginal pruritus, Thirst, Constipation, Nausea, Abdominal pain, Fatigue, Loss of strength or energy, Asthenia, Pancreatitis, Erythema, Rash, Pruritus, Urticaria, Angioedema, Photosensitivity reactions, Polymorphic light eruption, Sunburn, Volume Depletion-Related Adverse Reactions, Hypotension, Postural dizziness, Orthostatic hypotension, Syncope, Dehydration, Falls, Increases in Serum Potassium, Increases in Serum Magnesium, Increases in Serum Phosphate, Increases in Hemoglobin, Decreases in Bone Mineral Density."
165,INVOKANA,warnings and precautions,"hypotension, renal impairment, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increased LDL-C"
166,VORAXAZE,adverse reactions,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, nausea and/or vomiting, hypotension, headache, myelosuppression, mucositis, acute hepatitis, renal dysfunction and failure, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
167,VORAXAZE,warnings and precautions,"serious allergic reactions, anaphylactic reactions, erroneous measurement"
168,NESINA,adverse reactions,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, severe hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, death"
169,NESINA,warnings and precautions,"acute pancreatitis, hypersensitivity reactions, anaphylaxis, angioedema, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic failure, death, hypoglycemia, severe and disabling arthralgia, liver enzyme elevations, fatigue, anorexia, right upper abdominal discomfort, dark urine, jaundice"
170,GILENYA,adverse reactions,"brasradycardia, atrioventricular blocks, infections, progressive multifocal leukoencephalopathy, macular edema, posterior reversible encephalopathy syndrome, respiratory effects, liver injury, headache, liver transaminase elevation, diarrhea, cough, influenza, sinusitis, back pain, abdominal pain, pain in extremity, serum transaminase elevations, basal cell carcinoma, bronchitis, herpes zoster, tinea versicolor, bradycardia, migraine, nausea, asthenia, alopecia, actinic keratosis, blood triglycerides increased, dyspnea, vision blurred, hypertension, lymphopenia, leukopenia, skin papilloma, dizziness, pneumonia, eczema, pruritus, ischemic stroke, hemorrhagic stroke, peripheral arterial occlusive disease, lymphoma"
171,GILENYA,warnings and precautions,"bradycardia, atrioventricular conduction, infections, progressive multifocal leukoencephalopathy (PML), macular edema, posterior reversible encephalopathy syndrome (PRES), decrease in pulmonary function tests (PFT), liver injury, blood pressure (BP) increase, symptomatic bradycardia, hypotension, dizziness, fatigue, palpitations, chest pain, first-degree AV block, second-degree AV blocks (Mobitz Types I [Wenckebach], 2:1 AV blocks), third-degree AV block, AV block with junctional escape, transient asystole, unexplained death, death, syncope, herpetic infections, bronchitis, herpes zoster, influenza, sinusitis, pneumonia, serious infections, disseminated primary herpes zoster, herpes simplex encephalitis, disseminated herpetic infections, multiorgan failure, cryptococcal infections, cryptococcal meningitis, varicella zoster virus infections, reductions in forced expiratory volume over 1 second (FEV1), diffusion lung capacity for carbon monoxide (DLCO), dyspnea, elevation of liver transaminases, jaundice, dark urine, fetal harm, hypertension, immune system effects after discontinuation."
172,HALAVEN,adverse reactions,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, headache, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, febrile neutropenia, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
173,HALAVEN,warnings and precautions,"neutropenia, severe neutropenia, ANC < 500/mm3, Grade 4 neutropenia, febrile neutropenia, alanine aminotransferase > 3 * ULN, aspartate aminotransferase > 3 * ULN, bilirubin > 1.5 * ULN, Grade 3 or 4 cytopenias, peripheral neuropathy, Grade 3 peripheral neuropathy, Grade 4 peripheral neuropathy, neuropathy lasting more than one year, peripheral motor neuropathy, peripheral sensory neuropathy, embryo-fetal toxicity, teratogenicity, fetal harm, QT prolongation, congestive heart failure, bradyarrhythmias, hypokalemia, hypomagnesemia"
174,INTELENCE,adverse reactions,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, pancreatitis, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, drug hypersensitivity, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, dry skin, swelling face, acquired lipodystrophy, angioneurotic edema, erythema multiforme, haemorrhagic stroke, Stevens-Johnson syndrome, erythema multiforme, DRESS, rhabdomyolysis, toxic epidermal necrolysis, death"
175,INTELENCE,warnings and precautions,"severe skin reactions, life threatening skin reactions, fatal skin reactions, Stevens-Johnson syndrome, hypersensitivity reaction, toxic epidermal necrolysis, erythema multiforme, severe hypersensitivity, severe rash, rash with systemic symptoms, liver transaminase elevations, Drug Rash with Eosinophilia and Systemic Symptoms (DRESS), rash, constitutional findings, organ dysfunction, hepatic failure, Grade 3 and 4 rashes, mild rash, severe rash accompanied by fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, facial edema, hepatitis, eosinophilia, angioedema, death, redistribution/accumulation of body fat, central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, cushingoid appearance, immune reconstitution syndrome, inflammatory response to indolent or residual opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
176,AMYVID,adverse reactions,"headache, musculoskeletal pain, blood pressure increased, fatigue, nausea, injection site reaction, anxiety, back pain, claustrophobia, dizziness, feeling cold, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing"
177,AMYVID,warnings and precautions,"image interpretation errors, false negatives, radiation risk, cumulative radiation exposure, increased risk of cancer, motion artifacts, brain atrophy."
178,ULESFIA,adverse reactions,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, pain, pruritus, erythema, pyoderma, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, rash, skin exfoliation"
179,ULESFIA,warnings and precautions,"gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death, eye irritation, contact dermatitis"
180,OTEZLA,adverse reactions,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, frequent bowel movement, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, tension headache, fatigue, insomnia, back pain, depression, bronchitis, tooth abscess, folliculitis, sinus headache, severe worsening of psoriasis (rebound)"
181,OTEZLA,warnings and precautions,"depression, suicidal thoughts, mood changes, weight decrease, clinically significant weight loss, weight loss, drug interactions, loss of efficacy, discontinued treatment due to depression, depression or depressed mood, depression as serious, suicidal ideation and behavior, suicidal behavior, attempted suicide, death."
182,ILARIS,adverse reactions,"upper respiratory tract infections, infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, tonsillitis, urinary tract infection, viral infection, injection site reaction (mild), injection site reaction (moderate), hypersensitivity, decreased white blood cell counts, neutropenia, thrombocytopenia, elevated transaminases, elevated bilirubin"
183,ILARIS,warnings and precautions,"serious infections, infections, upper respiratory tract infections, unusual infections, opportunistic infections, aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster, tuberculosis, reactivation of latent tuberculosis, hypersensitivity reactions, immunosuppression, malignancies, Macrophage Activation Syndrome (MAS), death"
184,NATAZIA,adverse reactions,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraines, breast pain, menstrual disorders, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, abdominal pain, vomiting, acne, mood changes, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, increased weight, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia of the liver, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, arterial thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, vulvovaginal candidiasis"
185,NATAZIA,boxed warnings,serious cardiovascular events
186,NATAZIA,warnings and precautions,"thrombotic event, thrombosis, arterial thromboses, strokes, myocardial infarctions, VTE (venous thromboembolism), cerebrovascular events, thrombotic strokes, hemorrhagic strokes, thromboembolic disease, retinal vein thrombosis, arterial thromboses, jaundice, hepatic adenomas, intra-abdominal hemorrhage, hepatocellular carcinoma, cholestasis, increased blood pressure, hypertension, gallbladder disease, decreased glucose tolerance, dyslipidemia, adverse lipid changes, hypertriglyceridemia, pancreatitis, headache, migraine, breakthrough bleeding, spotting, bleeding irregularities, amenorrhea, oligomenorrhea, intracyclic bleeding, birth defects, teratogenic effect, depression, changes in laboratory test results, hereditary angioedema, chloasma, death"
187,DIFICID,adverse reactions,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
188,DIFICID,warnings and precautions,"acute hypersensitivity reactions, angioedema, dyspnea, pruritus, rash, development of drug-resistant bacteria"
189,ONFI,adverse reactions,"Somnolence, Sedation, Potentiation of Sedation, Withdrawal Symptoms, Serious Dermatological Reactions, Physical and Psychological Dependence, Suicidal Behavior and Ideation, Constipation, Pyrexia, Lethargy, Drooling, Ataxia, Aggression, Fatigue, Insomnia, Vomiting, Dysphagia, Irritability, Upper respiratory tract infection, Pneumonia, Urinary tract infection, Bronchitis, Decreased appetite, Increased appetite, Psychomotor hyperactivity, Dysarthria, Cough, Anemia, Eosinophilia, Leukopenia, Thrombocytopenia, Diplopia, Vision blurred, Abdominal distention, Hypothermia, Hepatic enzyme increased, Muscle spasms, Agitation, Anxiety, Apathy, Confusional state, Depression, Delirium, Delusion, Hallucination, Urinary retention, Aspiration, Respiratory depression, Rash, Urticaria, Angioedema, Facial and lip edema"
190,ONFI,warnings and precautions,"somnolence, sedation, central nervous system (CNS) depression, withdrawal symptoms, rapid dose reduction, discontinuation, serious dermatological reactions, Stevens-Johnson syndrome, toxic epidermal necrolysis, physical dependence, psychological dependence, suicidal behavior, ideation, convulsions, psychosis, hallucinations, behavioral disorder, tremor, anxiety, seizure exacerbation, status epilepticus, dysphoria, insomnia, depression, mood changes, suicidal thoughts, self-harm"
191,TECFIDERA,adverse reactions,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, eosinophilia"
192,TECFIDERA,warnings and precautions,"anaphylaxis, angioedema, difficulty breathing, urticaria, swelling of the throat and tongue, Progressive Multifocal Leukoencephalopathy (PML), death, lymphopenia, prolonged lymphopenia, progressive weakness, clumsiness of limbs, disturbance of vision, changes in thinking, memory disturbances, confusion, personality changes, decrease in lymphocyte counts, infections, serious infections, flushing, warmth, redness, itching, burning sensation"
193,DYSPORT,adverse reactions,"Distant Spread of Toxin Effect, Lack of Interchangeability between Botulinum Toxin Products, Spread of Effects from Toxin, Dysphagia, Breathing Difficulties, Facial Anatomy in the Treatment of Glabellar Lines, Pre-existing Neuromuscular Disorders, Human Albumin, Intradermal Immune Reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, blurred vision, diplopia, reduced visual acuity, accommodation issues, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, dyspnea, blood glucose increase, heart rate reduction, blood present in urine, injection site bruising, injection site reaction, injection site erythema, injection site haematoma, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, facial paresis, eyelid ptosis, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, photophobia, influenza-like illness, amyotrophy, burning sensation, hypoesthesia, erythema, excessive granulation tissue, vertigo, gait disturbance, hypertonia, sensation of heaviness, antibodiesformation (binding or neutralizing)"
194,DYSPORT,boxed warnings,"asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death"
195,DYSPORT,warnings and precautions,"respiratory difficulties, speech difficulties, swallowing difficulties, concomitant neuromuscular disorder exacerbation, Creutzfeldt-Jakob disease (CJD) risk, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, breathing difficulties, death, severe dysphagia, aspiration, neck muscle weakness, respiratory failure, surgical alterations to facial anatomy, excessive weakness, muscle atrophy, marked facial asymmetry, inflammation at injection site, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, eyelid ptosis, peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, neuromuscular junction disorders, severe dysphagia (again mentioned), respiratory compromise, immune reaction, intradermal immune reaction"
196,ZYTIGA,adverse reactions,"Hypertension, Hypokalemia, Fluid Retention, Mineralocorticoid Excess, Adrenocortical Insufficiency, Hepatotoxicity, Fatigue, Joint Swelling, Discomfort, Edema, Hot Flush, Diarrhea, Vomiting, Cough, Dyspnea, Urinary Tract Infection, Contusion, Anemia, Elevated Alkaline Phosphatase, Hypertriglyceridemia, Lymphopenia, Hypercholesterolemia, Hyperglycemia, Elevated AST, Hypophosphatemia, Elevated ALT, Muscle Discomfort, Dyspepsia, Upper Respiratory Tract Infection, Urinary Frequency, Nocturia, Fractures, Arrhythmia, Chest Pain, Chest Discomfort, Cardiac Failure, Pyrexia, Groin Pain, Constipation, Insomnia, Falls, Nasopharyngitis, Hematuria, Rash, Hypernatremia, Non-infectious Pneumonitis, Myopathy, Rhabdomyolysis, Death."
197,ZYTIGA,warnings and precautions,"Mineralocorticoid excess, cardiovascular disease, LVEF < 50%, NYHA Class III heart failure, NYHA Class IV heart failure, NYHA Class II heart failure, hypertension, hypokalemia, fluid retention edema, adrenocortical insufficiency, hepatotoxicity, liver enzymes increase, drug interruption, dose modification, liver function discontinuation, grade 3 hypertension, grade 4 hypertension, grade 3 hypokalemia, grade 4 hypokalemia, grade 3 edema, grade 4 edema, myocardial infarction, ventricular arrhythmia, adrenal insufficiency, placebo, prednisone, infection, stress, ALT increase, AST increase, 5* ULN (Upper Limit of Normal), baseline ALT elevation, baseline AST elevation, liver test elevation, liver enzyme increases, serum transaminases, bilirubin levels, moderate hepatic impairment, serum total bilirubin, AST and ALT rise above five times ULN, bilirubin rises above three times ULN, liver function tests to baseline, AST and ALT less than or equal to 2.5* ULN, total bilirubin less than or equal to 1.5* ULN, AST or ALT greater than or equal to 20* ULN, bilirubin greater than or equal to 10* ULN, death"
198,DUAVEE,adverse reactions,"Cardiovascular Disorders, Malignant Neoplasms, Gallbladder Disease, Hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, all-cause mortality, serious adverse reactions, hot flush, Venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, death"
199,DUAVEE,boxed warnings,"endometrial cancer, cardiovascular disorders, probable dementia, stroke, deep vein thrombosis (DVT), blood clots, breast cancer, cancer of the ovary, gallbladder problems, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of other medical problems such as asthma, diabetes, epilepsy, migraines, a genetic problem called porphyria, lupus and liver problems, new breast lumps, changes in vision or speech, sudden new severe headaches, severe pains in your chest or legs with or without shortness of breath, weakness and fatigue, muscle spasms, nausea, diarrhea, upset stomach, abdominal pain, throat pain, dizziness, neck pain"
200,DUAVEE,warnings and precautions,"cardiovascular disorders, venous thromboembolism, pulmonary embolism, stroke, retinal vascular thrombosis, malignant neoplasms, endometrial cancer, breast cancer, ovarian cancer, gallbladder disease, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, visual abnormalities, elevated blood pressure, hypertriglyceridemia, hepatic impairment, hypothyroidism, fluid retention, hypocalcemia, hereditary angioedema, exacerbation of asthma, exacerbation of diabetes mellitus, exacerbation of epilepsy, exacerbation of migraine, exacerbation of porphyria, exacerbation of systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance"
201,SAPHRIS,adverse reactions,"Use in Elderly Patients with Dementia-Related Psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, Hypersensitivity Reactions, Application site reactions, Oral ulcers, Blisters, Peeling/sloughing, Inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, Seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, Akathisia, Oral hypoesthesia, Somnolence, Dizziness, Extrapyramidal symptoms, Increased weight, Dysgeusia, Nausea, Increased appetite, Fatigue, Constipation, Dry mouth, Salivary hypersecretion, Stomach discomfort, Vomiting, Irritability, Headache, Insomnia, Hypertension, Anxiety, Depression, Oral paraesthesia, Tachycardia, Glossodynia, Edema peripheral, Dysmenorrhea, Oropharyngeal pain, Nasal congestion, Dyspnea, Rash, Parkinsonism, Suicidal ideation, Anger, Anemia, Thrombocytopenia, Temporary bundle branch block, Accommodation disorder, Swollen tongue, Idiosyncratic drug reaction, Hyponatremia, Dysarthria, Diplopia, Vision blurred, Gastroesophageal reflux disease, Fall, Photosensitivity reaction, Enuresis, Choking, Death"
202,SAPHRIS,boxed warnings,"increased mortality, death"
203,SAPHRIS,warnings and precautions,"cerebrovascular adverse events, stroke, transient ischemic attack, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, metabolic changes, cardiovascular/cerebrovascular risk, hyperglycemia, dyslipidemia, weight gain, Hypersensitivity Reactions, anaphylaxis, angioedema, Orthostatic Hypotension, Syncope, Hemodynamic Effects, dizziness, tachycardia, bradycardia, Leukopenia, Neutropenia, Agranulocytosis, QT Prolongation, Seizures, Cognitive impairment, Motor Impairment, Suicide, increased mortality, death, blood pressure abnormalities, diaphoresis, cardiac dysrhythmia, altered mental status, muscle rigidity, hyperpyrexia, creatine phosphokinase elevation, myoglobinuria, rhabdomyolysis, acute renal failure, dyskinetic movements, hypotension, white blood cell count decline, fever, infection, electrolyte imbalances, Hyperprolactinemia, galactorrhea, amenorrhea, gynecomastia, impotence, bone density decrease, somnolence, body temperature regulation disruption, pyrexia, feeling hot, Dysphagia, esophageal dysmotility, aspiration pneumonia, aspiration, myocardial infarction, heart failure, ischemic heart disease, conduction abnormalities, unstable heart disease, respiratory depression, central nervous system depression, prolactin level elevation, hypothalamic GnRH suppression, gonadotropin secretion inhibition, reproductive function impairment, gonadal steroidogenesis inhibition, heat stroke, drug fever, central anticholinergic toxicity, primary central nervous system pathology, dehydration, hypovolemia, anticholinergic activity, dementia-related psychosis"
204,DUREZOL,adverse reactions,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritis, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, scleral hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis"
205,DUREZOL,warnings and precautions,"Intraocular pressure increase, glaucoma, damage to optic nerve, defects in visual acuity, defects in fields of vision, cataracts, posterior subcapsular cataract formation, delayed healing, increase in incidence of bleb formation, corneal or scleral thinning, corneal or scleral perforations, bacterial infections, suppression of host response, secondary ocular infections, masking of infection, enhancement of existing infection, viral infections, exacerbation of viral infections, exacerbation of herpes simplex, prolongation of viral infections course, fungal infections, corneal fungal infections, persistent corneal ulceration, fungus invasion"
206,ZYDELIG,adverse reactions,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, sepsis, febrile neutropenia, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, bronchitis, sinusitis, urinary tract infection, arthralgia, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased"
207,ZYDELIG,boxed warnings,"hepatic toxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, death"
208,ZYDELIG,warnings and precautions,"severe cutaneous reactions, anaphylaxis, neutropenia, embryo-fetal toxicity, hepatotoxicity, elevated ALT, elevated AST, severe diarrhea, colitis, pneumonitis, cough, dyspnea, hypoxia, interstitial infiltrates, decline in oxygen saturation, intestinal perforation, toxic epidermal necrolysis (TEN), dermatitis exfoliative, rash, rash erythematous, rash generalized, rash macular, rash maculo-papular, rash papular, rash pruritic, exfoliative rash, skin disorder, allergic reactions, teratogenic effects, fetal harm, death"
209,KALBITOR,adverse reactions,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, erythema, pain, irritation, urticaria, bruising, neutralizing antibodies, anti-ecallantide IgE antibodies, anti-P. pastoris IgE antibodies"
210,KALBITOR,boxed warnings,"anaphylaxis, hypersensitivity reactions"
211,KALBITOR,warnings and precautions,"Hypersensitivity Reactions, Anaphylaxis, chest discomfort, flushing, pharyngeal edema, pruritus, rhinorrhea, sneezing, nasal congestion, throat irritation, urticaria, wheezing, hypotension, rash"
212,ADCETRIS,adverse reactions,"Peripheral Neuropathy, Anaphylaxis, Infusion Reactions, Hematologic Toxicities, Serious Infections, Opportunistic Infections, Tumor Lysis Syndrome, Severe Renal Impairment, Moderate or Severe Hepatic Impairment, Hepatotoxicity, Progressive Multifocal Leukoencephalopathy (PML), Pulmonary Toxicity, Serious Dermatologic Reactions, Neutropenia, Peripheral Sensory Neuropathy, Fatigue, Nausea, Anemia, Upper Respiratory Tract Infection, Diarrhea, Pyrexia, Rash, Thrombocytopenia, Cough, Vomiting, Peripheral Motor Neuropathy, Lymphadenopathy, Headache, Dizziness, Chills, Pain, Edema Peripheral, Constipation, Pruritus, Alopecia, Night Sweats, Dry Skin, Dyspnea, Oropharyngeal Pain, Arthralgia, Myalgia, Back Pain, Pain in Extremity, Muscle Spasms, Insomnia, Anxiety, Decreased Appetite, Weight Decreased, Febrile Neutropenia, Hyperglycemia, Pancreatitis, Pneumonitis, Interstitial Lung Disease, Acute Respiratory Distress Syndrome (ARDS), Toxic Epidermal Necrolysis,death."
213,ADCETRIS,boxed warnings,"Progressive Multifocal Leukoencephalopathy (PML), JC virus infection, death"
214,ADCETRIS,warnings and precautions,"peripheral neuropathy, hypoesthesia, hyperesthesia, paresthesia, discomfort, burning sensation, neuropathic pain, weakness, anaphylaxis, infusion reactions, hematologic toxicities, neutropenia, fever, thrombocytopenia, anemia, febrile neutropenia, serious infections, opportunistic infections, pneumonia, bacteremia, sepsis, septic shock, tumor lysis syndrome, hepatotoxicity, elevation of transaminases, elevation of bilirubin, hepatocellular injury, progressive multifocal leukoencephalopathy (PML), pulmonary toxicity, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), cough, dyspnea, serious dermatologic reactions, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), embryo-fetal toxicity, fetal harm, fetal malformations, death"
215,BESIVANCE,adverse reactions,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
216,BESIVANCE,warnings and precautions,"Topical Ophthalmic Use Only, Growth of Resistant Organisms with Prolonged Use, Avoidance of Contact Lenses, overgrowth of non-susceptible organisms, super-infection, signs or symptoms of bacterial conjunctivitis"
217,CLEVIPREX,adverse reactions,"hypotension, reflex tachycardia, headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, decreased oxygen saturation (possible pulmonary shunting)"
218,CLEVIPREX,warnings and precautions,"hypotension, reflex tachycardia, negative inotropic effects, exacerbation of heart failure, rebound hypertension, disorders of lipid metabolism"
219,XTANDI,adverse reactions,"seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, spinal cord compression and cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, non-pathologic fracture, neutropenia, thrombocytopenia, elevations in ALT, elevations in bilirubin, infections, falls and fall-related injuries, death"
220,XTANDI,warnings and precautions,seizure
221,BOSULIF,adverse reactions,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, hematology parameters, platelet count low, absolute neutrophil count low, hemoglobin low, biochemistry parameters, SGPT/ALT elevated, SGOT/AST elevated, lipase greater than 2*ULN, phosphorus low, total bilirubin elevated, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, chest pain, hepatotoxicity, toxic hepatitis, cytolytic hepatitis, abnormal hepatic function, liver disorder, liver injury, drug hypersensitivity, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption"
222,BOSULIF,warnings and precautions,"Gastrointestinal Toxicity, Diarrhea, Nausea, Vomiting, Abdominal Pain, Myelosuppression, Thrombocytopenia, Anemia, Neutropenia, Hepatic Toxicity, Drug Induced Liver Injury, Elevations in ALT, Elevations in AST, Fluid Retention, Pericardial Effusion, Pleural Effusion, Pulmonary Edema, Peripheral Edema, Renal Toxicity, Decline in eGFR, Kidney Failure, Embryofetal Toxicity, Fetal Harm"
223,CARBAGLU,adverse reactions,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash"
224,CARBAGLU,warnings and precautions,"Hyperammonemia, injury to the brain, death, brain injury/damage, acute symptomatic hyperammonemia."
225,SIMPONI,adverse reactions,"Serious Infections, Malignancies, upper respiratory tract infection, viral infection, bronchitis, hypertension, rash, sepsis, pneumonia, cellulitis, abscess, opportunistic infections, tuberculosis, invasive fungal infections, Liver Enzyme Elevations, autoimmune disorders, autoantibodies, lupus-like syndrome, positive anti-dsDNA antibodies, administration reactions, infusion reaction, Immunogenicity, antibodies to SIMPONI ARIA, neutralizing antibodies, Other Adverse Reactions, Pyrexia, Leukopenia, Superficial fungal infection, sinusitis, lower respiratory tract infection, pyelonephritis, Alanine aminotransferase increased, aspartate aminotransferase increased, neutrophil count decreased, Dizziness, paresthesia, Constipation, Neoplasm Benign and Malignant, melanoma, Immune System Disorders, systemic hypersensitivity reactions, anaphylactic reaction, sarcoidosis, Respiratory, thoracic and mediastinal disorders, Interstitial lung disease, Skin and subcutaneous tissue disorders, Skin exfoliation, bullous skin reactions"
226,SIMPONI,boxed warnings,"serious infections, hospitalization, death, tuberculosis (TB), bacterial sepsis, invasive fungal infections, histoplasmosis, opportunistic infections, sepsis, lymphoma, malignancies, active tuberculosis, latent tuberculosis, disseminated disease, extrapulmonary disease, invasive fungal infections, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial infections, viral infections, infections due to opportunistic pathogens, Legionella, Listeria."
227,SIMPONI,warnings and precautions,"serious infections, invasive fungal infections, Hepatitis B reactivation, malignancies, lymphoma, heart failure, demyelinating disease, hypersensitivity reactions, anaphylaxis, opportunistic infections, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis, tuberculosis, sepsis, Hepatitis B Virus reactivation, death, acute and chronic leukemia, hepatosplenic T-cell lymphoma, melanoma, Merkel cell carcinoma, congestive heart failure, worsening congestive heart failure, new onset CHF, central nervous system demyelinating disorders, multiple sclerosis, peripheral demyelinating disorders, Guillain-Barre syndrome, central demyelination, optic neuritis, peripheral demyelinating polyneuropathy, serious infections, neutropenia, pancytopenia, leukopenia, neutropenia, aplastic anemia, thrombocytopenia"
228,BENLYSTA,adverse reactions,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, nausea, diarrhea, pyrexia, nasopharyngitis, bronchitis, insomnia, pain in extremity, migraine, pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, erythematous rash, pruritus, eyelid edema, headache, dyspnea, Fatal anaphylaxis, death"
229,BENLYSTA,warnings and precautions,"mortality, deaths, serious infections, infections, fatal infections, chronic infections, Progressive Multifocal Leukoencephalopathy (PML), neurological signs and symptoms, Hypersensitivity Reactions, Anaphylaxis, serious reactions, fatal reactions, Depression, suicidality, new or worsening depression, suicidal thoughts, mood changes, Live vaccines, Malignancy, malignancies, non-melanoma skin cancers, risk for the development of malignancies, acute hypersensitivity reactions, death, rash, nausea, fatigue, myalgia, headache, facial edema, hypersensitivity, Anaphylaxis, hypotension, angioedema, urticaria, pruritus, dyspnea, Infusion Reactions, bradycardia, serious infusion reactions, skin reactions, psychiatric events, depression-related events, insomnia, anxiety, serious psychiatric events, serious depression, suicides, Immunization, Concomitant Use with Other Biologic Therapies or Intravenous Cyclophosphamide, death."
230,TOVIAZ,adverse reactions,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, angina, chest pain, gastroenteritis, QT prolongation, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation"
231,TOVIAZ,warnings and precautions,"angioedema, urinary retention, severe constipation, narrow-angle glaucoma, somnolence, headache, dizziness, central nervous system effects, severe hepatic impairment, severe renal impairment, death"
232,ENTEREG,adverse reactions,dyspepsia
233,ENTEREG,boxed warnings,"myocardial infarction, increased risk of myocardial infarction, greater incidence of myocardial infarction"
234,ENTEREG,warnings and precautions,"myocardial infarctions, abdominal pain, nausea and vomiting, diarrhea, serious adverse reactions, increased plasma levels of drug, dose-related serious adverse reactions, death"
235,VIZAMYL,adverse reactions,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death"
236,VIZAMYL,warnings and precautions,"hypersensitivity reactions, flushing, dyspnea, image interpretation errors, false positives, radiation risk, cancer, unintentional radiation exposure"
237,AMPYRA,adverse reactions,"Seizures, Anaphylaxis, Urinary Tract Infections, death, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events, confusional state"
238,AMPYRA,warnings and precautions,"seizures, anaphylaxis, renal impairment, urinary tract infections (UTIs), respiratory compromise, urticaria, angioedema"
239,ADCETRIS,all-concat,"peripheral neuropathy, anaphylaxis, infusion reactions, hematologic toxicities, serious infections, opportunistic infections, tumor lysis syndrome, severe renal impairment, moderate hepatic impairment, severe hepatic impairment, hepatotoxicity, progressive multifocal leukoencephalopathy, pulmonary toxicity, serious dermatologic reactions, embryo-fetal toxicity, neutropenia, peripheral sensory neuropathy, fatigue, nausea, anemia, upper respiratory tract infection, diarrhea, pyrexia, rash, thrombocytopenia, cough, vomiting, peripheral motor neuropathy, abdominal pain, lymphadenopathy, headache, dizziness, chills, pain, edema peripheral, constipation, pruritus, alopecia, night sweats, dry skin, dyspnea, oropharyngeal pain, arthralgia, myalgia, back pain, pain in extremity, muscle spasms, insomnia, anxiety, decreased appetite, weight decreased, febrile neutropenia, hyperglycemia, pancreatitis, pneumonitis, interstitial lung disease, acute respiratory distress syndrome (ARDS), toxic epidermal necrolysis, Stevens-Johnson syndrome, death"
240,ADREVIEW,all-concat,"hypersensitivity reactions, dizziness, rash, pruritis, flushing, headache, injection site hemorrhage, hematoma, bruising, benzyl alcohol toxicity, hypotension, metabolic acidosis, kernicterus, increased radiation exposure, decreased quality of scintigraphic images, hypertension, death"
241,AFINITOR,all-concat,"non-infectious pneumonitis, infections, angioedema, oral ulceration, renal failure, impaired wound healing, death, stomatitis, rash, fatigue, diarrhea, edema, abdominal pain, nausea, fever, asthenia, cough, headache, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, increased aspartate transaminase (AST), anemia, leukopenia, thrombocytopenia, lymphopenia, increased alanine transaminase (ALT), hypertriglyceridemia, lymphopenia, hyperglycemia, decreased potassium, diarrhoea, mouth ulceration, aphthous stomatitis, glossodynia, gingival pain, glossitis, lip ulceration, nasopharyngitis, urinary tract infection, upper respiratory tract infection, pneumonia, bronchitis, cystitis, sinusitis, candidiasis, sepsis, hepatitis C, pneumonitis, interstitial lung disease, lung infiltration, pulmonary fibrosis, weight decreased, hyperglycemia, arthralgia, back pain, pain in extremity, dysgeusia, insomnia, epistaxis, pruritus, alopecia, hot flush, hemoglobin decreased, WBC decreased, platelets decreased, lymphocytes decreased, neutrophils decreased, glucose increased, cholesterol increased, triglycerides increased, albumin decreased, creatinine increased, acute renal failure, renal failure, acute respiratory distress, cardiac arrest, hepatic failure, sepsis, pulmonary embolism, myocardial infarction, congestive heart failure, sudden death, pneumonia, renal failure, thrombotic events, stomatitis, rash, diarrhea, fatigue, edema, abdominal pain, nausea, fever, headache, abdominal pain, diabetes mellitus, arthralgia, back pain, pain in extremity, muscle spasms, cough, dyspnea, dry skin, xeroderma, hypertension, anemia, leucopenia, neutropenia, hypercholesterolemia, hypertriglyceridemia, hypophosphatemia, elevated aspartate transaminase (AST), increased alanine transaminase (ALT), fasting hyperglycemia, asthenia, fatigue, cough, diarrhea, nausea, vomiting, mucosal inflammation, rash, pruritus, dry skin, anorexia, headache, pain in extremity, stomatitis, vomiting, diarrhea, peripheral edema, upper respiratory tract infection, arthralgia, cough, acne, amenorrhea, menorrhagia, menstrual irregularities, vaginal hemorrhage, epistaxis, decreased appetite, otitis media, depression, abnormal taste, increased blood luteinizing hormone (LH), increased blood follicle stimulating hormone (FSH), hypersensitivity, ovarian cyst, pneumonitis, angioedema, respiratory tract infection, gastroenteritis, pyrexia, fatigue, anxiety, aggression, behavioral disturbance, panic attack, abnormal behavior, obsessive compulsive disorder, rash, acne, hemorrhoids, dysphagia, weight decreased, chest pain, chills, impaired wound healing, pleural effusion, pharyngolaryngeal pain, rhinorrhea, hand-foot syndrome, palmar-plantar erythrodysesthesia syndrome, nail disorder, erythema, onychoclasis, skin lesion, acneiform dermatitis, exacerbation of pre-existing diabetes mellitus, new onset of diabetes mellitus, insomnia, dizziness, paresthesia, eyelid edema, conjunctivitis, hypertension, deep vein thrombosis, renal failure, congestive cardiac failure, jaw pain, hemorrhage, acute pancreatitis, cholecystitis, cholelithiasis, arterial thrombotic events, reflex sympathetic dystrophy"
242,AMPYRA,all-concat,"Seizures, Anaphylaxis, Urinary Tract Infections, urinary tract infection, insomnia, dizziness, headache, nausea, asthenia, back pain, balance disorder, multiple sclerosis relapse, paresthesia, nasopharyngitis, constipation, dyspepsia, pharyngolaryngeal pain, treatment emergent adverse events, confusional state, renal impairment, severe allergic reactions, respiratory compromise, urticaria, angioedema"
243,AMYVID,all-concat,"headache, musculoskeletal pain, blood pressure increased, hypertension, fatigue, nausea, injection site reaction, injection site haemorrhage, injection site irritation, injection site pain, anxiety, back pain, claustrophobia, dizziness, feeling cold, chills, insomnia, neck pain, infusion site rash, dysgeusia, pruritis, urticaria, flushing, image interpretation errors, radiation risk, cancer"
244,APTIOM,all-concat,"Suicidal Behavior and Ideation, Serious Dermatologic Reactions, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), Multiorgan Hypersensitivity, Anaphylactic Reactions, Angioedema, Hyponatremia, Neurological Adverse Reactions, Drug Induced Liver Injury, Abnormal Thyroid Function Tests, dizziness, somnolence, nausea, headache, diplopia, vomiting, fatigue, vertigo, ataxia, blurred vision, tremor, death, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), rash, lymphadenopathy, hepatitis, nephritis, hematological abnormalities, myocarditis, myositis, hypochloremia, seizure, severe nausea/vomiting, dehydration, severe gait instability, injury, disturbance in gait and coordination, balance disorder, gait disturbance, nystagmus, abnormal coordination, asthenia, malaise, hypersomnia, sedation, lethargy, memory impairment, disturbance in attention, amnesia, confusional state, aphasia, speech disorder, slowness of thought, disorientation, psychomotor retardation, diplopia, visual impairment, cough, urinary tract infections, fall, peripheral edema, hypertension, depression, insomnia, ear and labyrinth disorders, gastrointestinal disorders, infections and infestations, injury, poisoning and procedural complications, metabolism and nutrition disorders, nervous system disorders, psychiatric disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, vascular disorders, decreases in hemoglobin and hematocrit, increases in total cholesterol, triglycerides, LDL, increases in creatine phosphokinase."
245,ARCAPTA,all-concat,"asthma-related death, cough, oropharyngeal pain, nasopharyngitis, headache, nausea, COPD, dyspnea, COPD exacerbation, pneumonia, angina pectoris, atrial fibrillation, muscle spasm, musculoskeletal pain, edema peripheral, diabetes mellitus, hyperglycemia, sinusitis, upper respiratory tract infection, hypersensitivity reactions, paradoxical bronchospasm, tachycardia, heart rate increase, palpitations, pruritus, rash, dizziness, death"
246,BELEODAQ,all-concat,"Hematologic Toxicity, Infection, Hepatotoxicity, Tumor Lysis Syndrome, Gastrointestinal Toxicity, nausea, fatigue, pyrexia, anemia, vomiting, Constipation, Diarrhea, Dyspnea, Rash, Peripheral Edema, Cough, Thrombocytopenia, Pruritus, Chills, Increased Blood Lactate Dehydrogenase, Decreased Appetite, Headache, Infusion Site Pain, Hypokalemia, Prolonged QT, Abdominal pain, Hypotension, Phlebitis, Dizziness, pneumonia, increased creatinine, multi-organ failure, death, febrile neutropenia, leukopenia (neutropenia, lymphopenia), serious infections, sepsis, liver function test abnormalities, fetal harm, teratogenicity, embryo-fetal lethality, genotoxicity."
247,BENLYSTA,all-concat,"Mortality, Serious Infections, Malignancy, Hypersensitivity Reactions, Anaphylaxis, Infusion Reactions, Depression, Nausea, Diarrhea, Pyrexia, Nasopharyngitis, Bronchitis, Insomnia, Pain in extremity, Migraine, Pharyngitis, Cystitis, Leukopenia, Gastroenteritis viral, Fatal anaphylaxis, Progressive Multifocal Leukoencephalopathy (PML), Infections, Upper respiratory tract infection, Urinary tract infection, Sinusitis, Influenza, Pneumonia, Cellulitis, Lupus nephritis, Infections leading to discontinuation, Infections resulting in death, JC virus-associated PML, Non-melanoma skin cancers, Acute hypersensitivity reactions, Non-acute hypersensitivity reactions, Rash, Fatigue, Myalgia, Headache, Facial edema, Bradycardia, Urticaria, Hypotension, Skin reactions, Suicidality, Anxiety, Serious psychiatric events, Serious depression, Suicides, death"
248,BEPREVE,all-concat,"mild taste following instillation, eye irritation, headache, nasopharyngitis, hypersensitivity reactions, itching, body rash, swelling of lips, tongue and/or throat."
249,BESIVANCE,all-concat,"conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, headache"
250,BLINCYTO,all-concat,"Cytokine Release Syndrome, Neurological Toxicities, Infections, Tumor Lysis Syndrome, Neutropenia, Febrile Neutropenia, Effects on Ability to Drive and Use Machines, Elevated Liver Enzymes, Leukoencephalopathy, Preparation and Administration Errors, Pyrexia, Headache, Peripheral Edema, Nausea, Hypokalemia, Tremor, Rash, Constipation, Pneumonia, Sepsis, Device-related infection, Encephalopathy, Overdose, Confusion, Staphylococcal bacteremia, Anemia, Thrombocytopenia, Leukopenia, Diarrhea, Abdominal pain, Vomiting, Fatigue, Chills, Chest pain, Cytokine release syndrome, Other pathogen infections, Bacterial infections, Fungal infections, Viral infections, Increased alanine aminotransferase, Increased aspartate aminotransferase, Hypomagnesemia, Hyperglycemia, Decreased appetite, Hypophosphatemia, Back pain, Pain in extremity, Bone pain, Arthralgia, Dizziness, Insomnia, Cough, Dyspnea, Hypotension, Hypertension, Leukocytosis, Lymphopenia, Tachycardia, Edema, Cytokine storm, Decreased immunoglobulins, Increased blood bilirubin, Increased gamma-glutamyl-transferase, Tumor lysis syndrome, Hypoalbuminemia, Paresthesia, Aphasia, Convulsion, Memory impairment, Cognitive disorder, Speech disorder, Capillary leak syndrome, Hypersensitivity, Bronchospasm, Death"
251,BOSULIF,all-concat,"gastrointestinal toxicity, myelosuppression, hepatic toxicity, fluid retention, renal toxicity, diarrhea, nausea, thrombocytopenia, vomiting, abdominal pain, rash, anemia, pyrexia, fatigue, anaphylactic shock, increased alanine aminotransferase, headache, cough, increased aspartate aminotransferase, neutropenia, edema, arthralgia, decreased appetite, respiratory tract infection, nasopharyngitis, back pain, asthenia, pruritus, dizziness, dyspnea, QTcF interval prolongation, platelet count low, absolute neutrophil count low, hemoglobin low, SGPT/ALT elevation, SGOT/AST elevation, lipase elevation, phosphorus low, total bilirubin high, febrile neutropenia, pericardial effusion, pericarditis, tinnitus, gastritis, acute pancreatitis, gastrointestinal hemorrhage, gastric hemorrhage, upper gastrointestinal hemorrhage, chest pain, chest discomfort, pain, toxic hepatitis, cytolytic hepatitis, liver disorder, liver injury, drug hypersensitivity, pneumonia, bronchopneumonia, lobar pneumonia, primary atypical pneumonia, influenza, bronchitis, electrocardiogram QT prolonged, increased blood creatine phosphokinase, increased blood creatinine, hyperkalemia, dehydration, myalgia, dysgeusia, acute renal failure, renal failure, pleural effusion, acute pulmonary edema, respiratory failure, pulmonary hypertension, urticaria, acne, erythema multiforme, exfoliative rash, drug eruption, embryofetal toxicity, death"
252,BREO,all-concat,"asthma-related death, death, adverse reactions, nasopharyngitis, upper respiratory tract infection, headache, oral candidiasis, Candida albicans infection, pneumonia, immunosuppression, hypercorticism, adrenal suppression, reduction in bone mineral density, bronchitis, sinusitis, oropharyngeal pain, dysphonia, cough, back pain, arthralgia, influenza, pharyngitis, pyrexia, extrasystoles, upper abdominal pain, respiratory tract infection, allergic rhinitis, rhinitis, supraventricular extrasystoles, ventricular extrasystoles, acute sinusitis, palpitations, tachycardia, anaphylaxis, angioedema, rash, urticaria, muscle spasms, tremor, nervousness, paradoxical bronchospasm, deterioration of disease, excessive use, local effects, immunosuppression including from systemic corticosteroids, transferring patients from systemic corticosteroid therapy, hypercorticism and adrenal suppression, strong cytochrome P450 3A4 inhibitors interaction, hypersensitivity reactions including anaphylaxis, cardiovascular effects, reduction in BMD, glaucoma, cataracts, coexisting conditions, hypokalemia, hyperglycemia, effect on growth."
253,CARBAGLU,all-concat,"Infections, vomiting, abdominal pain, pyrexia, tonsilitis, anemia, ear infection, diarrhea, nasopharyngitis, headache, dysgeusia, asthenia, hyperhidrosis, influenza, pneumonia, hemoglobin decreased, weight decreased, anorexia, somnolence, rash, hyperammonemia, brain injury, death"
254,CERDELGA,all-concat,"fatigue, headache, nausea, diarrhea, back pain, pain in extremities, upper abdominal pain, arthralgia, migraine, flatulence, oropharyngeal pain, dizziness, asthenia, cough, dyspepsia, gastroesophageal reflux disease, constipation, palpitations, rash, ECG changes, cardiac arrhythmias, increases in ECG intervals, PR interval prolongation, QTc interval prolongation, QRS interval prolongation."
255,CHOLINE,all-concat,"mild injection site reaction, imaging errors, allergic reactions, anaphylaxis, radiation risk, tissue inflammation, false positive imaging, false negative imaging, cancer risk, death"
256,CIMZIA,all-concat,"upper respiratory tract infection, rash, urinary tract infection, serious infections, malignancies, heart failure, abdominal pain, diarrhea, intestinal obstruction, tuberculosis infections, pyrexia, urticaria, pneumonia, nasopharyngitis, laryngitis, viral infection, bladder infection, bacteriuria, cystitis, arthralgia, anemia, leukopenia, lymphadenopathy, pancytopenia, thrombophilia, angina pectoris, arrhythmias, atrial fibrillation, cardiac failure, hypertensive heart disease, myocardial infarction, myocardial ischemia, pericardial effusion, pericarditis, stroke, transient ischemic attack, optic neuritis, retinal hemorrhage, uveitis, bleeding, injection site reactions, elevated liver enzymes, hepatitis, alopecia totalis, anxiety, bipolar disorder, suicide attempt, nephrotic syndrome, renal failure, menstrual disorder, dermatitis, erythema nodosum, thrombophlebitis, vasculitis, headache, hypertension, back pain, pharyngitis, acute bronchitis, fatigue, systemic vasculitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, new or worsening psoriasis, sarcoidosis, active tuberculosis, latent tuberculosis, invasive fungal infections, histoplasmosis, coccidioidomycosis, candidiasis, aspergillosis, blastomycosis, pneumocystosis, bacterial sepsis, opportunistic infections, Legionella, Listeria, lymphoma, Hodgkin's lymphoma, anaphylaxis, severe hypersensitivity reactions, hepatitis B virus reactivation, demyelinating disease, multiple sclerosis, Guillain-Barre syndrome, seizure disorder, peripheral neuropathy, aplastic anemia, lupus-like syndrome, hematologic abnormalities, autoantibodies, immunosuppression, death"
257,CLEVIPREX,all-concat,"headache, nausea, vomiting, acute renal failure, atrial fibrillation, myocardial infarction, cardiac arrest, syncope, dyspnea, increased blood triglycerides, ileus, hypersensitivity, hypotension, decreased oxygen saturation, reflex tachycardia, negative inotropic effects, rebound hypertension, death"
258,COARTEM,all-concat,"headache, anorexia, dizziness, asthenia, arthralgia, myalgia, pyrexia, cough, vomiting, chills, fatigue, malaise, nausea, abdominal pain, diarrhea, sleep disorder, insomnia, palpitations, hepatomegaly, splenomegaly, anemia, pruritus, rash, vertigo, nasopharyngitis, eosinophilia, tinnitus, conjunctivitis, constipation, dyspepsia, dysphagia, peptic ulcer, gait disturbance, abscess, acrodermatitis, bronchitis, ear infection, gastroenteritis, helminthic infection, hookworm infection, impetigo, influenza, lower respiratory tract infection, oral herpes, pneumonia, respiratory tract infection, subcutaneous abscess, upper respiratory tract infection, urinary tract infection, alanine aminotransferase increased, hematocrit decreased, lymphocyte morphology abnormal, platelet count decreased, platelet count increased, white blood cell count decreased, white blood cell count increased, hypokalemia, back pain, ataxia, clonus, fine motor delay, hyperreflexia, hypoesthesia, nystagmus, tremor, agitation, mood swings, hematuria, proteinuria, asthma, pharyngo-laryngeal pain, urticaria, anaphylaxis, angioedema, bullous eruption, QT prolongation, death"
259,COMETRIQ,all-concat,"perforations, fistula, hemorrhage, thromboembolic events, wound complications, hypertension, osteonecrosis of the jaw, palmar-plantar erythrodysesthesia syndrome, proteinuria, reversible posterior leukoencephalopathy syndrome, diarrhea, stomatitis, decreased weight, decreased appetite, nausea, fatigue, oral pain, hair color changes, dysgeusia, abdominal pain, constipation, increased AST, increased ALT, lymphopenia, increased alkaline phosphatase, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, hyperbilirubinemia, septicemia, pneumonia, general deterioration, cardiac arrest, respiratory failure, unspecified death, asthenia, dehydration, arthralgia, muscle spasms, musculoskeletal chest pain, dysgeusia, headache, dizziness, paresthesia, peripheral sensory neuropathy, peripheral neuropathy, anxiety, dysphonia, hair color changes, depigmentation, graying, rash, dry skin, alopecia, erythema, hyperkeratosis, hypotension, increased AST, increased ALT, increased ALP, hypocalcemia, hypophosphatemia, hyperbilirubinemia, hypomagnesemia, hypokalemia, hyponatremia, lymphopenia, neutropenia, thrombocytopenia, death"
260,DALVANCE,all-concat,"nausea, headache, diarrhea, vomiting, rash, pruritus, anemia, hemorrhagic anemia, leucopenia, neutropenia, thrombocytopenia, petechiae, eosinophilia, thrombocytosis, gastrointestinal hemorrhage, melena, hematochezia, abdominal pain, infusion-related reactions, hepatotoxicity, anaphylactoid reaction, Clostridium difficile colitis, oral candidiasis, vulvovaginal mycotic infection, hepatic transaminases increased, blood alkaline phosphatase increased, international normalized ratio increased, hypoglycemia, dizziness, bronchospasm, urticaria, flushing, phlebitis, wound hemorrhage, spontaneous hematoma, hypersensitivity reaction, anaphylactic reaction, skin reactions, ""Red-Man Syndrome"", liver test abnormalities, ALT elevation, AST elevation, bilirubin increase, CDAD, drug-resistant bacteria"
261,DATSCAN,all-concat,"hypersensitivity, injection site reactions, headache, nausea, vertigo, dry mouth, dizziness, rash, pruritis, skin erythema, injection site pain, thyroid neoplasia"
262,DIFICID,all-concat,"nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, neutropenia, abdominal distension, abdominal tenderness, dyspepsia, dysphagia, flatulence, intestinal obstruction, megacolon, increased blood alkaline phosphatase, decreased blood bicarbonate, increased hepatic enzymes, decreased platelet count, hyperglycemia, metabolic acidosis, drug eruption, pruritus, rash, hypersensitivity reactions, dyspnea, angioedema"
263,DOTAREM,all-concat,"NSF, hypersensitivity reactions, acute kidney injury, death, nausea, headache, injection site pain, injection site coldness, burning sensation, feeling cold, rash, somnolence, fatigue, dizziness, vomiting, pruritus, paresthesia, dysgeusia, pain in extremity, anxiety, hypertension, palpitations, oropharyngeal discomfort, serum creatinine increased, injection site reactions, injection site inflammation, injection site extravasation, injection site pruritus, injection site warmth, bradycardia, tachycardia, arrhythmia, cardiac arrest, respiratory arrest, cyanosis, pharyngeal edema, laryngospasm, bronchospasm, angioedema, conjunctivitis, ocular hyperemia, eyelid edema, lacrimation increased, hyperhidrosis, urticaria, coma, convulsion, syncope, presyncope, parosmia, tremor, muscle contracture, muscle weakness, diarrhea, salivary hypersecretion, malaise, fever, superficial phlebitis, anaphylactoid reactions, cardiovascular reactions, respiratory reactions, cutaneous manifestations, circulatory collapse, anaphylactic reactions, allergic disorders, bronchial asthma, extravasation, tissue irritation"
264,DUAVEE,all-concat,"cardiovascular disorders, malignant neoplasms, gallbladder disease, hypertriglyceridemia, muscle spasms, nausea, diarrhea, dyspepsia, abdominal pain upper, oropharyngeal pain, dizziness, neck pain, venous thromboembolism, deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, endometrial cancer, stroke, probable dementia, hot flush, blood clots, strokes, dementia, getting strokes, getting blood clots, getting dementia, cancer of the uterus, cancer of the breast, ovarian cancer, usual vaginal bleeding, breast cancer, loss of vision, high blood pressure, increased fats in your blood, liver problems, thyroid problems, fluid retention, low calcium, swelling of your mouth or tongue, worsening of asthma, diabetes, epilepsy, migraines, porphyria, lupus, liver problems, allergic reactions, blood clots, strokes, heart attack, gallbladder problems, loss of vision, severe hypertriglyceridemia, cholestatic jaundice, visual abnormalities, retinal vascular thrombosis, elevated blood pressure, hypothyroidism, hereditary angioedema, exacerbation of asthma, diabetes mellitus, epilepsy, migraine, porphyria, systemic lupus erythematosus, hepatic hemangiomas, impaired glucose tolerance, death"
265,DUREZOL,all-concat,"elevated intraocular pressure, optic nerve damage, visual acuity defects, field defects, posterior subcapsular cataract formation, secondary ocular infection, herpes simplex, perforation of the globe, corneal thinning, scleral thinning, corneal edema, ciliary hyperemia, conjunctival hyperemia, eye pain, photophobia, posterior capsule opacification, anterior chamber cells, anterior chamber flare, conjunctival edema, blepharitis, reduced visual acuity, punctate keratitis, eye inflammation, iritis, application site discomfort, application site irritation, corneal pigmentation, corneal striae, episcleritis, eye pruritus, eyelid irritation, eyelid crusting, foreign body sensation, increased lacrimation, macular edema, sclera hyperemia, uveitis, blurred vision, headache, increased IOP, limbal hyperemia, dry eye, iridocyclitis, glaucoma, defects in visual acuity, defects in fields of vision, bleb formation, bacterial infections, viral infections, fungal infections, corneal ulceration, corneal fungal invasion"
266,DYSPORT,all-concat,"distant spread of toxin effect, lack of interchangeability between botulinum toxin products, spread of effects from toxin, dysphagia, breathing difficulties, facial anatomy in the treatment of glabellar lines, pre-existing neuromuscular disorders, human albumin, intradermal immune reaction, muscular weakness, dry mouth, injection site discomfort, fatigue, headache, neck pain, musculoskeletal pain, dysphonia, injection site pain, eye disorders, nasopharyngitis, upper respiratory tract infection, eyelid edema, eyelid ptosis, sinusitis, nausea, urinary tract infection, dizziness, fall, depression, asthenia, generalized muscle weakness, diplopia, ptosis, dysarthria, urinary incontinence, breathing difficulties, disturbance in attention, eyelid disorder, feeling abnormal, muscle atrophy, blood glucose increase, heart rate reduction, blood present in urine, bronchitis, influenza, pharyngolaryngeal pain, cough, contact dermatitis, injection site swelling, injection site bruising, numbness, discomfort, erythema, tenderness, tingling, itching, stinging, warmth, irritation, tightness, swelling, pain in extremity, back pain, convulsion, syncope, hypoaesthesia, partial seizures, asthenia, injury, contusion, diarrhea, constipation, blood triglycerides increased, hypertension, vertigo, photophobia, influenza-like illness, amyotrophy, burning sensation, facial paresis, hypoesthesia, erythema, excessive granulation tissue, dysphagia, gait disturbance, hypertonia, sensation of heaviness, death"
267,EDARBI,all-concat,"diarrhea, hypotension, orthostatic hypotension, nausea, asthenia, fatigue, muscle spasm, dizziness, dizziness postural, cough, serum creatinine increases, low hemoglobin, low hematocrit, low RBC counts, abnormal platelet counts, abnormal WBC counts, rash, pruritus, angioedema, fetal toxicity, oligohydramnios, fetal lung hypoplasia, skeletal deformations, skull hypoplasia, anuria, hypotension in neonates, renal failure, death"
268,ELIQUIS,all-concat,"thrombotic events, bleeding, Spinal/epidural anesthesia or puncture, hemorrhage (including major, intracranial, gastrointestinal, fatal, intracranial, non-intracranial, hemorrhagic stroke, upper GI, lower GI, rectal), anaphylactic reactions, allergic edema, syncope, hypersensitivity reactions (including skin rash), Hematoma, Nausea, Anemia (including postoperative and hemorrhagic anemia), Contusion, hemorrhage (including hematoma, and vaginal and urethral hemorrhage), Postprocedural hemorrhage (including postprocedural hematoma, wound hemorrhage, vessel puncture site hematoma and catheter site hemorrhage), Transaminases increased (including alanine aminotransferase increased and alanine aminotransferase abnormal), Aspartate aminotransferase increased, Gamma-glutamyltransferase increased, thrombocytopenia (including platelet count decreases), hypotension (including procedural hypotension), epistaxis, hematochezia, hematuria, menorrhagia, hemoptysis, gingival bleeding, hemorrhagic anemia, gastrointestinal hemorrhage (including hematemesis and melena), anal hemorrhage, wound hemorrhage, traumatic hematoma, periorbital hematoma, muscle hemorrhage, vaginal hemorrhage, metrorrhagia, menometrorrhagia, genital hemorrhage, hemorrhage, ecchymosis, skin hemorrhage, petechiae, conjunctival hemorrhage, retinal hemorrhage, eye hemorrhage, blood urine present, occult blood positive, occult blood, red blood cells urine positive, injection-site hematoma, vessel puncture-site hematoma, death"
269,ENTEREG,all-concat,"dyspepsia, myocardial infarction, abdominal pain, nausea, vomiting, diarrhea, serious adverse reactions, death"
270,EOVIST,all-concat,"Nephrogenic systemic fibrosis (NSF), Hypersensitivity reactions, nausea, headache, feeling hot, dizziness, back pain, vomiting, increased blood pressure, injection site reactions (pain, burning, coldness, extravasation, irritation), dysgeusia, paresthesia, flushing, parosmia, pruritus (generalized, eye), rash, respiratory disorders (dyspnea, respiratory distress), fatigue, chest pain, vertigo, dry mouth, chills, feeling abnormal, tremor, akathisia, bundle branch block, palpitation, oral discomfort, salivary hypersecretion, maculopapular rash, hyperhidrosis, discomfort, malaise, anaphylactic shock, hypotension, pharyngolaryngeal edema, urticaria, face edema, rhinitis, conjunctivitis, abdominal pain, hypoesthesia, sneezing, cough, pallor, tachycardia, restlessness, death"
271,ERWINAZE,all-concat,"Hypersensitivity reactions, anaphylaxis, pancreatitis, severe pancreatitis, hemorrhagic pancreatitis, glucose intolerance, hyperglycemia, thrombosis, hemorrhage, sagittal sinus thrombosis, pulmonary embolism, coagulopathy, allergy, enzyme abnormalities, hyperbilirubinemia, hyperlipidemia, ketoacidosis, CNS events, adverse events, allergic reactions, thrombotic events, hemorrhagic events, hepatobiliary disorders, pancreatic disorders, death"
272,EYLEA,all-concat,"Endophthalmitis, retinal detachments, Increased intraocular pressure, Thromboembolic events, Conjunctival hemorrhage, Eye pain, Cataract, Vitreous floaters, Vitreous detachment, Ocular hyperemia, Corneal epithelium defect, Detachment of the retinal pigment epithelium, Injection site pain, Foreign body sensation in eyes, Lacrimation increased, Vision blurred, Intraocular inflammation, Retinal pigment epithelium tear, Injection site hemorrhage, Eyelid edema, Corneal edema, Hypersensitivity, Retinal tear, Death"
273,FANAPT,all-concat,"dizziness, dry mouth, fatigue, nasal congestion, orthostatic hypotension, somnolence, tachycardia, weight increased, arthralgia, musculoskeletal stiffness, vision blurred, nausea, diarrhea, abdominal discomfort, nasopharyngitis, upper respiratory tract infection, extrapyramidal disorder, tremor, lethargy, ejaculation failure, dyspnea, rash, hypotension, palpitations, vertigo, tinnitus, hypothyroidism, conjunctivitis, gastritis, salivary hypersecretion, fecal incontinence, mouth ulceration, aphthous stomatitis, duodenal ulcer, hiatus hernia, hyperchlorhydria, lip ulceration, reflux esophagitis, stomatitis, edema, difficulty in walking, thirst, hyperthermia, cholelithiasis, weight decreased, anemia, iron deficiency anemia, leukopenia, increased appetite, dehydration, hypokalemia, fluid retention, myalgia, muscle spasms, torticollis, paresthesia, psychomotor hyperactivity, restlessness, amnesia, nystagmus, restless legs syndrome, aggression, delusion, hostility, libido decreased, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, bulimia nervosa, delirium, polydipsia psychogenic, impulse-control disorder, major depression, urinary incontinence, dysuria, pollakiuria, enuresis, nephrolithiasis, urinary retention, renal failure acute, erectile dysfunction, testicular pain, amenorrhea, breast pain, menstruation irregular, gynecomastia, menorrhagia, metrorrhagia, postmenopausal hemorrhage, prostatitis, epistaxis, asthma, rhinorrhea, sinus congestion, nasal dryness, dry throat, sleep apnea syndrome, dyspnea exertional, retrograde ejaculation, death, cerebrovascular adverse events, stroke, QT prolongation, arrhythmia, sudden death, Neuroleptic Malignant Syndrome, Tardive dyskinesia, Hyperglycemia, diabetes mellitus, Dyslipidemia, Seizures, Leukopenia, Neutropenia, Agranulocytosis, Suicide, Priapism, cognitive and motor impairment, increased mortality in elderly patients with dementia-related psychosis"
274,FARXIGA,all-concat,"hypotension, impairment in renal function, renal failure, blood creatinine increase, hypoglycemia, genital mycotic infections, vulvovaginal mycotic infection, vaginal infection, vulvovaginal candidiasis, vulvovaginitis, genital infection, genital candidiasis, fungal genital infection, vulvitis, genitourinary tract infection, vulval abscess, vaginitis bacterial, nasopharyngitis, urinary tract infections, cystitis, Escherichia urinary tract infection, pyelonephritis, trigonitis, urethritis, kidney infection, prostatitis, back pain, increased urination, pollakiuria, polyuria, urine output increased, male genital mycotic infections, balanitis, balanitis candida, genital infection male, penile infection, balanoposthitis, balanoposthitis infective, nausea, influenza, dyslipidemia, constipation, discomfort with urination, pain in extremity, volume depletion, dehydration, hypovolemia, orthostatic hypotension, hypersensitivity reactions, angioedema, urticaria, anaphylactic reactions, severe cutaneous adverse reactions, increase in hematocrit, increase in serum inorganic phosphorus, increase in low-density lipoprotein cholesterol (LDL-C), bladder cancer, bone fractures"
275,FERRIPROX,all-concat,"chromaturia, nausea, vomiting, abdominal pain, alanine aminotransferase increased, arthralgia, neutropenia, agranulocytosis, diarrhea, dyspepsia, neutrophil count decreased, weight increased, aspartate aminotransferase increased, increased appetite, decreased appetite, back pain, pain in extremity, arthropathy, headache, thrombocytosis, pancytopenia, atrial fibrillation, cardiac failure, hypospadias, diplopia, papilledema, retinal toxicity, enterocolitis, rectal hemorrhage, gastric ulcer, pancreatitis, parotid gland enlargement, chills, pyrexia, edema peripheral, multi-organ failure, jaundice, hepatomegaly, anaphylactic shock, hypersensitivity, cryptococcal cutaneous infection, enteroviral encephalitis, pharyngitis, pneumonia, sepsis, furuncle, infectious hepatitis, rash pustular, subcutaneous abscess, blood bilirubin increased, blood creatinine phosphokinase increased, metabolic acidosis, dehydration, myositis, chondropathy, trismus, cerebellar syndrome, cerebral hemorrhage, convulsion, gait disturbance, intracranial pressure increased, psychomotor skills impaired, pyramidal tract syndrome, somnolence, bruxism, depression, obsessive-compulsive disorder, glycosuria, hemoglobinuria, acute respiratory distress syndrome, epistaxis, hemoptysis, pulmonary embolism, hyperhidrosis, periorbital edema, photosensitivity reaction, pruritis, urticaria, rash, Henoch-Schonlein purpura, hypotension, hypertension, death"
276,FIRAZYR,all-concat,"injection site reactions, pyrexia, transaminase increase, dizziness, rash, nausea, headache, hypersensitivity, anaphylactic reactions, laryngeal attacks"
277,FULYZAQ,all-concat,"Upper respiratory tract infection, Bronchitis, Cough, Flatulence, Increased bilirubin, Nausea, Back pain, Arthralgia, Urinary tract infection, Nasopharyngitis, Musculoskeletal pain, Hemorrhoids, Giardiasis, Anxiety, Increased alanine aminotransferase, Abdominal distension, Abdominal pain, Acne, Increased aspartate aminotransferase, Increased conjugated bilirubin, Increased unconjugated blood bilirubin, Constipation, Depression, Dermatitis, Dizziness, Dry mouth, Dyspepsia, Gastroenteritis, Herpes zoster, Nephrolithiasis, Pain in extremity, Pollakiuria, Procedural pain, Seasonal allergy, Sinusitis, Decreased white blood cell count"
278,GADAVIST,all-concat,"Nephrogenic Systemic Fibrosis (NSF), Hypersensitivity reactions, headache, nausea, dizziness, Dysgeusia, Feeling Hot, Injection site reactions, Vomiting, Rash (includes generalized, macular, papular, pruritic), Pruritus (includes generalized), Erythema, Hypersensitivity/Anaphylactoid*, Dyspnea, Paresthesia, loss of consciousness, convulsion, parosmia, tachycardia, palpitation, dry mouth, malaise, feeling cold, Cardiac arrest, anaphylactic shock, circulatory collapse, respiratory arrest, pulmonary edema, bronchospasm, cyanosis, oropharyngeal swelling, laryngeal edema, blood pressure increased, chest pain, angioedema, conjunctivitis, hyperhidrosis, cough, sneezing, burning sensation, pallor, death"
279,GILENYA,all-concat,"Bradyarrhythmia, Atrioventricular Blocks, Infections, Progressive multifocal leukoencephalopathy (PML), Macular Edema, Posterior Reversible Encephalopathy Syndrome (PRES), Respiratory Effects, Liver Injury, Headache, Liver transaminase elevation, Diarrhea, Cough, Influenza, Sinusitis, Back pain, Abdominal pain, Pain in extremity, Serum transaminase elevations, Basal cell carcinoma, Influenza, Sinusitis, Bronchitis, Herpes zoster, Tinea versicolor, Bradycardia, Headache, Migraine, Nausea, Diarrhea, Abdominal pain, Asthenia, Back pain, Pain in extremity, Alopecia, Actinic keratosis, Blood triglycerides increased, Cough, Dyspnea, Vision blurred, Hypertension, Lymphopenia, Leukopenia, Skin papilloma, Basal cell carcinoma, Dizziness, Pneumonia, Eczema, Pruritus, Vascular Events, Ischemic stroke, Hemorrhagic stroke, Peripheral arterial occlusive disease, Lymphomas, Death (due to herpetic infections), Herpes Viral Infections, Cryptococcal infections, Varicella Zoster Virus, Blood pressure effects, Immune system effects, Hypotension, Fatigue, Palpitations, Chest pain, Atropine or isoproterenol treatment required, Third-degree AV block, AV block with junctional escape, Transient asystole, Unexplained death, Syncope, Bronchitis, Herpes zoster, Pneumonia, Herpes simplex encephalitis, Varicella zoster multiorgan failure, Disseminated primary herpes zoster, Cryptococcal meningitis, Antineoplastic therapies, Immunosuppressive therapies, Immune-Modulating therapies, Varicella zoster virus vaccination, Forced expiratory volume reduction (FEV1), Diffusion lung capacity for carbon monoxide reduction (DLCO), Unexplained nausea, Vomiting, Anorexia, Jaundice, Dark urine, Severe hepatic impairment, Fetal harm, Systolic pressure increase, Diastolic pressure increase, Hypertension, Decreased lymphocyte counts."
280,GILOTRIF,all-concat,"diarrhea, bullous skin disorders, exfoliative skin disorders, interstitial lung disease, hepatic toxicity, keratitis, rash, dermatitis acneiform, stomatitis, paronychia, dry skin, decreased appetite, nausea, vomiting, pruritus, pulmonary toxicity, ILD-like adverse reactions, sepsis, pneumonia, ventricular dysfunction, diastolic dysfunction, left ventricular dysfunction, ventricular dilation, epistaxis, rhinorrhea, weight decreased, pyrexia, conjunctivitis, alanine aminotransferase increased, hypokalemia, aspartate aminotransferase increased, pancreatitis, dehydration, renal failure, bullous skin reactions, blistering skin reactions, exfoliating lesions, palmar-plantar erythrodysesthesia syndrome, lung infiltration, pneumonitis, acute respiratory distress syndrome, alveolitis allergic, liver test abnormalities, eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain, red eye, ulcerative keratitis, severe dry eye, abortions, embryotoxic, death"
281,GRANIX,all-concat,"Splenic Rupture, Acute Respiratory Distress Syndrome (ARDS), Serious Allergic Reactions, anaphylaxis, angioneurotic edema, dermatitis allergic, drug hypersensitivity, hypersensitivity, rash, pruritic rash, urticaria, Sickle cell crisis, Capillary Leak Syndrome (CLS), hypotension, hypoalbuminemia, edema, hemoconcentration, Tumor Growth Stimulatory Effects on Malignant Cells, bone pain, Leukocytosis, myalgia, headache, vomiting, Sweet's syndrome, acute febrile neutrophilic dermatosis, cutaneous vasculitis, thrombocytopenia, immunogenicity, death"
282,HALAVEN,all-concat,"neutropenia, anemia, asthenia/fatigue, alopecia, peripheral neuropathy, nausea, constipation, febrile neutropenia, mucosal inflammation, pyrexia, diarrhea, vomiting, arthralgia/myalgia, back pain, bone pain, pain in extremity, weight decreased, anorexia, cough, dyspnea, urinary tract infection, cytopenias, thrombocytopenia, peripheral motor neuropathy, liver function test abnormalities, ALT elevation, increased lacrimation, dyspepsia, abdominal pain, stomatitis, dry mouth, peripheral edema, upper respiratory tract infection, hypokalemia, muscle spasms, muscular weakness, dysgeusia, dizziness, insomnia, depression, rash, lymphopenia, pancreatitis, hepatotoxicity, drug hypersensitivity, pneumonia, sepsis/neutropenic sepsis, hypomagnesemia, dehydration, interstitial lung disease, pruritus, death"
283,HORIZANT,all-concat,"somnolence, sedation, dizziness, RLS, headache, nausea, dry mouth, flatulence, fatigue, irritability, feeling drunk, feeling abnormal, peripheral edema, weight increased, increased appetite, vertigo, depression, libido decreased, balance disorder, blurred vision, disorientation, lethargy, breast enlargement, gynecomastia, elevated creatine kinase, driving impairment, suicidal thoughts, behaviors, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), multiorgan hypersensitivity, withdrawal seizure, pancreas acinar cell adenoma, carcinoma, breast tumor, brain tumor, lung tumor, adrenal tumor, non-Hodgkin's lymphoma, endometrial carcinoma in situ"
284,ILARIS,all-concat,"infections, upper respiratory tract infections, serious infections, opportunistic infections, nasopharyngitis, diarrhea, influenza, headache, nausea, abdominal pain, injection site reactions, vertigo, rhinitis, bronchitis, gastroenteritis, pharyngitis, weight increased, musculoskeletal pain, pneumonia, varicella, gastroenteritis, measles, sepsis, otitis media, sinusitis, adenovirus, lymph node abscess, injection site reaction (mild), injection site reaction (moderate), hypersensitivity, anaphylactic reactions, decreased white blood cell counts, neutropenia (including absolute neutrophil count decreases), thrombocytopenia (including mild and transient decreases in platelet counts), elevated transaminases (including ALT and/or AST increases), increased bilirubin, tuberculosis, latent tuberculosis infection, immunosuppression, risk of malignancies, macrophage activation syndrome (MAS), aspergillosis, atypical mycobacterial infections, cytomegalovirus, herpes zoster"
285,IMBRUVICA,all-concat,"hemorrhage, infections, cytopenias, atrial fibrillation, second primary malignancies, tumor lysis syndrome, thrombocytopenia, neutropenia, diarrhea, anemia, fatigue, musculoskeletal pain, bruising, nausea, upper respiratory tract infection, rash, peripheral edema, dyspnea, constipation, abdominal pain, vomiting, decreased appetite, pneumonia, skin infections, renal failure, creatinine increased, subdural hematoma, lymphocytosis, intracranial hemorrhage, lethargy, gait instability, headache, elevated uric acid levels, hyperuricemia, muscle spasms, arthralgia, cough, epistaxis, dehydration, dizziness, hemoglobin decreased, sinusitis, urinary tract infection, stomatitis, dyspepsia, pyrexia, asthenia, petechiae, chills, anxiety, insomnia, hypertension, vision blurred, contusion, pruritus, arthropathy, oropharyngeal pain, peripheral neuropathy, second malignancies, laceration, hypersensitivity reactions, anaphylactic shock, death, urticaria, angioedema, bleeding events (subdural hematoma, gastrointestinal bleeding, hematuria, post procedural hemorrhage), progressive multifocal leukoencephalopathy (PML), non-melanoma skin cancer, embryo-fetal toxicity, malformations in animals, reduced fetal weights."
286,INLYTA,all-concat,"hypertension, arterial thromboembolic events, venous thromboembolic events, hemorrhage, cardiac failure, gastrointestinal perforation, fistula formation, thyroid dysfunction, wound healing complications, RPLS (Reversible Posterior Leukoencephalopathy Syndrome), proteinuria, elevation of liver enzymes, hepatic impairment, fetal harm, death, diarrhea, fatigue, decreased appetite, nausea, dysphonia, palmar-plantar erythrodysesthesia (hand-foot) syndrome, weight decreased, vomiting, asthenia, constipation, hypothyroidism, cough, mucosal inflammation, arthralgia, stomatitis, dyspnea, abdominal pain, headache, pain in extremity, rash, proteinuria, dysgeusia, dry skin, dyspepsia, pruritus, alopecia, erythema, dizziness, upper abdominal pain, myalgia, dehydration, epistaxis, anemia, hemorrhoids, hematuria, tinnitus, lipase increased, glossodynia, pulmonary embolism, rectal hemorrhage, hemoptysis, deep vein thrombosis, retinal-vein occlusion/thrombosis, polycythemia, transient ischemic attack, hypertensive crisis, cerebrovascular accident, myocardial infarction, retinal artery occlusion, gastric hemorrhage, cerebral hemorrhage, lower gastrointestinal hemorrhage, melena, cardiac failure, hyperthyroidism, RPLS, moderate to severe proteinuria, ALT elevation, AST elevation, bilirubin elevation, hypercalcemia, hypocalcemia, hypoglycemia, hyponatremia, hypernatremia, hypoalbuminemia, hypophosphatemia, hyperkalemia, hypocalcemia, hyperglycemia, ALP increased, bicarbonate decreased, creatinine increased, white blood cells decreased, platelets decreased, lymphocytes (absolute) decreased, hemoglobin decreased."
287,INTELENCE,all-concat,"severe skin reactions, hypersensitivity reactions, rash, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug hypersensitivity reaction, erythema multiforme, myocardial infarction, angina pectoris, atrial fibrillation, vertigo, blurred vision, gastroesophageal reflux disease, flatulence, gastritis, abdominal distension, constipation, dry mouth, hematemesis, retching, stomatitis, sluggishness, hemolytic anemia, hepatic failure, hepatomegaly, cytolytic hepatitis, hepatic steatosis, hepatitis, immune reconstitution syndrome, diabetes mellitus, anorexia, dyslipidemia, paraesthesia, somnolence, convulsion, hypoesthesia, amnesia, syncope, disturbance in attention, hypersomnia, tremor, anxiety, sleep disorders, abnormal dreams, confusional state, disorientation, nervousness, nightmares, acute renal failure, gynecomastia, exertional dyspnea, bronchospasm, night sweats, lipohypertrophy, prurigo, hyperhidrosis, swelling face, acquired lipodystrophy, angioneurotic edema, haemorrhagic stroke, laboratory abnormalities, fatal events, death"
288,INVOKANA,all-concat,"hypotension, impairment in renal function, hyperkalemia, hypoglycemia, genital mycotic infections, hypersensitivity reactions, bone fracture, increases in low-density lipoprotein cholesterol (LDL-C), increased urination, male genital mycotic infections, vulvovaginal pruritus, thirst, constipation, nausea, abdominal pain, fatigue, loss of strength or energy (asthenia), pancreatitis (acute or chronic), erythema, rash, pruritus, urticaria, angioedema, photosensitivity-related adverse reactions, volume depletion-related adverse reactions (e.g., postural dizziness, orthostatic hypotension, syncope, dehydration), falls, increased blood creatinine, decreased glomerular filtration rate, renal impairment, acute renal failure, candidal balanitis, balanoposthitis, phimosis, increase in serum potassium, increase in serum magnesium, increase in serum phosphate, increase in non-high-density lipoprotein cholesterol (non-HDL-C), increases in hemoglobin, decreases in bone mineral density (BMD)"
289,JARDIANCE,all-concat,"hypotension, impairment in renal function, hypoglycemia, genital mycotic infections, urinary tract infections, increased Low-Density Lipoprotein Cholesterol (LDL-C), upper respiratory tract infection, increased urination, dyslipidemia, arthralgia, nausea, thirst, volume depletion, blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, orthostatic hypotension, syncope, polyuria, pollakiuria, nocturia, serum creatinine increase, eGFR decrease, genital infection fungal, vulvovaginal candidiasis, vulvitis, vaginal infection, phimosis, asymptomatic bacteriuria, cystitis, increase in hematocrit, female genital mycotic infections, male genital mycotic infections, balanoposthitis, balanitis, scrotal abscess, penile infection, vulvovaginal mycotic infection, genital candidiasis, genitourinary tract infection, vulvovaginitis, cervicitis, urogenital infection fungal, vaginitis bacterial"
290,JEVTANA,all-concat,"Bone Marrow Suppression, Hypersensitivity Reactions, Gastrointestinal Adverse Reactions, Renal Failure, Embryo-Fetal Toxicity, neutropenia, anemia, leukopenia, thrombocytopenia, diarrhea, fatigue, nausea, vomiting, constipation, asthenia, abdominal pain, hematuria, back pain, anorexia, peripheral neuropathy, pyrexia, dyspnea, dysgeusia, cough, arthralgia, alopecia, febrile neutropenia, infections, ventricular fibrillation, cerebral hemorrhage, Arrhythmia, Peripheral Edema, Mucosal Inflammation, Pain, Urinary Tract Infection, Weight Decreased, Dehydration, Muscle Spasms, Dizziness, Headache, Dysuria, Hypotension, Gastritis, intestinal obstruction, generalized rash/erythema, bronchospasm, Neutropenic deaths, sepsis, septic shock, increased AST, increased ALT, increased bilirubin, death."
291,JUBLIA,all-concat,"ingrown toenails, application site dermatitis, application site vesicles, application site pain"
292,KALBITOR,all-concat,"hypersensitivity reactions, anaphylaxis, headache, nausea, diarrhea, pyrexia, injection site reactions, nasopharyngitis, fatigue, upper respiratory tract infection, vomiting, pruritus, upper abdominal pain, chest discomfort, flushing, pharyngeal edema, rhinorrhea, sneezing, nasal congestion, throat irritation, wheezing, hypotension, rash, urticaria"
293,KALYDECO,all-concat,"Transaminase Elevations, Headache, Oropharyngeal Pain, Upper Respiratory Tract Infection, Nasal Congestion, Abdominal Pain, Nasopharyngitis, Diarrhea, Rash, Nausea, Dizziness, Hypoglycemia, Rhinitis, Aspartate Aminotransferase Increased, Bacteria in Sputum, Blood Glucose Increased, Hepatic Enzyme Increased, Arthralgia, Musculoskeletal Chest Pain, Myalgia, Sinus Headache, Pharyngeal Erythema, Pleuritic Pain, Sinus Congestion, Wheezing, Acne, Lens Opacities/Cataracts"
294,KYPROLIS,all-concat,"cardiac toxicities, cardiac failure, myocardial infarction, myocardial ischemia, death, acute renal failure, tumor lysis syndrome, pulmonary toxicity, pulmonary hypertension, dyspnea, hypertension, venous thrombosis, infusion reactions, thrombocytopenia, hepatic toxicity, hepatic failure, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), posterior reversible encephalopathy syndrome (PRES), embryo-fetal toxicity, Acute Respiratory Distress Syndrome (ARDS), acute respiratory failure, acute diffuse infiltrative pulmonary disease, pneumonitis, interstitial lung disease, Acute Renal Failure, anemia, fatigue, nausea, pyrexia, decreased platelets, diarrhea, decreased lymphocytes, headache, decreased hemoglobin, cough, edema peripheral, decreased absolute neutrophil count, decreased phosphorus, neutropenia, decreased total white blood cell count, muscle spasm, upper respiratory tract infection, hypokalemia, constipation, pneumonia, lymphopenia, leukopenia, vomiting, chills, asthenia, nasopharyngitis, bronchitis, hypokalemia, hypocalcemia, hyperglycemia, back pain, arthralgia, pain in extremity, muscle spasms, musculoskeletal pain, dizziness, peripheral neuropathies NEC, insomnia, dyspnea, epistaxis, renal failure, hypertension, febrile neutropenia, cardiac arrest, cardiac failure congestive, blurred vision, abdominal pain, abdominal pain upper, dyspepsia, toothache, infusion site reaction, multi-organ failure, pain, influenza, sepsis, urinary tract infection, viral infection, dehydration, hyperkalemia, hyperuricemia, hypoalbuminemia, hyponatremia, muscular weakness, myalgia, hypoesthesia, paresthesia, deafness, anxiety, delirium, renal impairment, dysphonia, oropharyngeal pain, pulmonary edema, erythema, hyperhidrosis, pruritus, deep vein thrombosis, hypotension, cardiac failure, restrictive cardiomyopathy, cardiac ischemia, cardiac arrest, acute respiratory distress syndrome,  pulmonary edema, decreased ejection fraction, volume overload, electrolyte abnormalities, pulmonary arterial hypertension, cardiopulmonary conditions, blood pressure, venous thromboembolic events, deep venous thrombosis, facial flushing, facial edema, weakness, shortness of breath, syncope, chest tightness, angina, platelet nadirs, serum transaminases, embryo-fetal toxicity, seizures, headache, lethargy, confusion, blindness, altered consciousness, visual disturbances, neurological disturbances."
295,LUMIZYME,all-concat,"anaphylaxis, hypersensitivity reactions, rash, pyrexia, flushing/feeling hot, urticaria, headache, hyperhidrosis, nausea, cough, decreased oxygen saturation, tachycardia, tachypnea, chest discomfort, dizziness, muscle twitching, agitation, cyanosis, erythema, hypertension/increased blood pressure, pallor, rigors, tremor, vomiting, fatigue, myalgia, acute cardiorespiratory failure, anaphylactic shock, respiratory failure, respiratory arrest, cardiac arrest, hypoxia, dyspnea, wheezing, convulsions, peripheral coldness, restlessness, nervousness, back pain, stridor, pharyngeal edema, abdominal pain, apnea, muscle spasm, conjunctivitis, proteinuria, nephrotic syndrome, necrotizing skin lesions, bradycardia, bronchospasm, throat tightness, hypotension, angioedema, urticaria, chest discomfort/pain, pruritus, flushing/feeling hot, pallor, restlessness, back pain, paresthesia, livedo reticularis, irritability, retching, increased lacrimation, ventricular extrasystoles, nodal rhythm, rales, respiratory tract irritation, cold sweat, local swelling, diarrhea, local swelling, pruritus, rash papular, edema peripheral, anaphylactic reactions, supraventricular tachycardia, flu-like illness, chills, arthralgia, pain, death"
296,MULTAQ,all-concat,"new or worsening heart failure, liver injury, pulmonary toxicity, hypokalemia, hypomagnesemia, QT prolongation, diarrhea, nausea, abdominal pain, vomiting, asthenia, premature discontinuation, gastrointestinal disorders, dyspeptic signs and symptoms, asthenic conditions, bradycardia, rashes, pruritus, eczema, dermatitis, dermatitis allergic, photosensitivity reaction, dysgeusia, early increases in creatinine, QTc prolonged, atrial flutter with 1:1 atrioventricular conduction, interstitial lung disease, pneumonitis, pulmonary fibrosis, anaphylactic reactions, angioedema, vasculitis, leukocytoclastic vasculitis, death, stroke, hepatocellular liver injury, acute liver failure, right upper quadrant pain, jaundice, dark urine, itching, onset of dyspnea, non-productive cough, marked increase in serum creatinine, pre-renal azotemia, acute renal failure, small increases in creatinine levels"
297,NATAZIA,all-concat,"serious cardiovascular events, stroke, vascular events, liver disease, irregular uterine bleeding, nausea, breast tenderness, headache, headaches, migraine, migraines, breast tenderness, pain, menstrual disorders, vomiting, acne, mood changes, increased weight, death, metrorrhagia, menorrhagia, menstruation irregular, genital hemorrhage, vaginal hemorrhage, dysfunctional uterine bleeding, depression, mood swings, mood altered, depressed mood, dysthymic disorder, crying, myocardial infarction, ruptured ovarian cyst, deep vein thrombosis, focal nodular hyperplasia, uterine leiomyoma, acute cholecystitis, chronic acalculous cholecystitis, venous thromboembolic events, pulmonary emboli, cerebral thrombosis, hypertension, gallbladder disease, hepatitis, hypersensitivity, fluid retention, hypertriglyceridemia, dizziness, chloasma, angioedema, erythema nodosum, erythema multiforme, gastrointestinal symptoms, abdominal pain, vulvovaginal candidiasis, retinal vein thrombosis, hepatocellular carcinoma, pancreatitis, amenorrhea, oligomenorrhea, intracyclic bleeding, birth defects, teratogenic effect, hereditary angioedema, chloasma gravidarum."
298,NESINA,all-concat,"nasopharyngitis, headache, upper respiratory tract infection, pancreatitis, hypersensitivity reactions, serum sickness, hypoglycemia, anaphylaxis, angioedema, rash, urticaria, severe cutaneous adverse reactions, Stevens-Johnson syndrome, hepatic enzyme elevations, fulminant hepatic failure, severe and disabling arthralgia, acute pancreatitis, liver injury"
299,NEURACEQ,all-concat,"injection site reaction, erythema, irritation, pain, image interpretation errors, false positives, radiation exposure, cancer"
300,NORTHERA,all-concat,"Supine Hypertension, Hyperpyrexia, Confusion, Ischemic Heart Disease, Arrhythmias, Congestive Heart Failure, Headache, Dizziness, Nausea, Hypertension, Fatigue, Increased Blood Pressure, Falls, Urinary Tract Infections, Syncope, Allergic Reactions, Death"
301,NULOJIX,all-concat,"PTLD, CNS PTLD, other malignancies, serious infections, JC virus-associated PML, polyoma virus nephropathy, anemia, diarrhea, urinary tract infection, peripheral edema, constipation, hypertension, pyrexia, graft dysfunction, cough, nausea, vomiting, headache, hypokalemia, hyperkalemia, leukopenia, cytomegalovirus infection, complications of transplanted kidney, post-transplant lymphoproliferative disorder, new or worsening neurological signs, cognitive signs, behavioral signs, opportunistic infections, tuberculosis, fungal infections, viral infections, protozoal infections, bacterial infections, cryptococcal meningitis, infusion reactions, proteinuria, immunogenicity, new-onset diabetes after transplantation, NODAT, dyslipidemia, hypertension, graft loss, upper respiratory infection, nasopharyngitis, influenza, bronchitis, abdominal pain, abdominal pain upper, hypophosphatemia, hypocalcemia, hyperglycemia, hypercholesterolemia, hematuria, dysuria, renal tubular necrosis, arthralgia, back pain, dizziness, tremor, acne, insomnia, anxiety, Guillain-Barre syndrome, stomatitis, aphthous stomatitis, chronic allograft nephropathy, neutropenia, renal impairment, acute renal failure, renal artery stenosis, urinary incontinence, hydronephrosis, hematoma, lymphocele, musculoskeletal pain, alopecia, hyperhidrosis, atrial fibrillation, death."
302,ONFI,all-concat,"somnolence, sedation, potentiation of sedation from concomitant use with CNS depressants, withdrawal symptoms, serious dermatological reactions, physical and psychological dependence, suicidal behavior and ideation, constipation, pyrexia, lethargy, drooling, lethargy, ataxia, aggression, fatigue, insomnia, vomiting, constipation, dysphagia, pyrexia, irritability, upper respiratory tract infection, pneumonia, urinary tract infection, bronchitis, decreased appetite, increased appetite, drooling, ataxia, psychomotor hyperactivity, dysarthria, aggression, cough, anemia, eosinophilia, leukopenia, thrombocytopenia, diplopia, vision blurred, abdominal distention, hypothermia, hepatic enzyme increased, muscle spasms, agitation, anxiety, apathy, confusional state, depression, delirium, delusion, hallucination, urinary retention, aspiration, respiratory depression, rash, urticaria, angioedema, facial and lip edema, Stevens-Johnson syndrome, toxic epidermal necrolysis, convulsions, psychosis, hallucinations, behavioral disorder, tremor"
303,OTEZLA,all-concat,"diarrhea, nausea, headache, upper respiratory tract infection, tension headache, vomiting, nasopharyngitis, abdominal pain upper, hypersensitivity, weight decrease, gastroesophageal reflux disease, dyspepsia, decreased appetite, migraine, cough, rash, depression, suicidal thoughts, suicidal behavior, weight loss, fatigue, insomnia, back pain, frequent bowel movements, bronchitis, tooth abscess, folliculitis, sinus headache, death"
304,PICATO,all-concat,"Ophthalmic Adverse Reaction, Hypersensitivity Reactions, local skin reactions, application site pain, application site pruritus, application site irritation, application site infection, periorbital edema, nasopharyngitis, headache, erythema, flaking/scaling, crusting, swelling, vesiculation/pustulation, erosion/ulceration, eyelid edema, eye pain, conjunctivitis, hypersensitivity, allergic contact dermatitis, herpes zoster, chemical conjunctivitis, corneal burn, eyelid ptosis, anaphylaxis"
305,POTIGA,all-concat,"retinal abnormalities, potential vision loss, urinary retention, skin discoloration, neuropsychiatric symptoms, dizziness, somnolence, QT interval effect, suicidal behavior and ideation, withdrawal seizures, fatigue, confusional state, vertigo, tremor, abnormal coordination, diplopia, disturbance in attention, memory impairment, asthenia, blurred vision, gait disturbance, aphasia, dysarthria, balance disorder, nausea, constipation, dyspepsia, influenza, weight increased, paresthesia, amnesia, dysphasia, anxiety, disorientation, psychotic disorder, dysuria, urinary hesitation, hematuria, chromaturia, increased appetite, hallucinations, myoclonus, peripheral edema, hypokinesia, dry mouth, dysphagia, hyperhydrosis, malaise, increased liver enzymes, rash, nystagmus, dyspnea, leukopenia, muscle spasms, alopecia, nephrolithiasis, syncope, neutropenia, thrombocytopenia, euphoric mood, renal colic, coma, encephalopathy, hydronephrosis, scleral discoloration, nail discoloration, mucous membrane discoloration, depression, worsening of depression, unusual changes in mood or behavior, thoughts about self-harm, renal function impairment."
306,PRADAXA,all-concat,"bleeding, gastritis-like symptoms, gastrointestinal hemorrhage, dyspepsia, nausea, upper abdominal pain, diarrhea, major bleeding, intracranial hemorrhage, hemorrhagic stroke, subarachnoid bleed, subdural bleed, gastrointestinal bleed, fatal bleeding, non-intracranial fatal bleed, hypersensitivity reactions, urticaria, rash, pruritus, allergic edema, anaphylactic reaction, anaphylactic shock, thrombocytopenia, esophageal ulcer, thrombotic events, spinal/epidural hematoma, myocardial infarction, bioprosthetic heart valves, thromboembolic events, valve thrombosis, stroke, transient ischemic attack, myocardial infarction, post-operative pericardial effusions, death"
307,PRISTIQ,all-concat,"Hypersensitivity, Suicidal Thoughts and Behaviors, Serotonin Syndrome, Elevated Blood Pressure, Abnormal Bleeding, Angle Closure Glaucoma, Activation of Mania/Hypomania, Discontinuation Syndrome, Seizure, Hyponatremia, Interstitial Lung Disease, Eosinophilic Pneumonia, nausea, dizziness, insomnia, hyperhidrosis, constipation, somnolence, decreased appetite, anxiety, specific male sexual function disorders, vomiting, headache, fatigue, chills, feeling jittery, decreased appetite, tremor, disturbance in attention, nervousness, abnormal dreams, urinary hesitation, yawning, vision blurred, mydriasis, vertigo, tinnitus, dysgeusia, hot flush, anorgasmia, libido decreased, orgasm abnormal, ejaculation delayed, erectile dysfunction, ejaculation disorder, ejaculation failure, sexual dysfunction, tachycardia, asthenia, weight increased, liver function test abnormal, blood prolactin increased, musculoskeletal stiffness, syncope, dystonia, depersonalization, bruxism, urinary retention, rash, alopecia, photosensitivity reaction, angioedema, myocardial ischemia, myocardial infarction, coronary occlusion requiring revascularization, Proteinuria, sustained hypertension, orthostatic hypotension, Stevens-Johnson syndrome, death."
308,PROLIA,all-concat,"Hypocalcemia, Serious Infections, Dermatologic Adverse Reactions, Osteonecrosis of the Jaw, Atypical Subtrochanteric and Diaphyseal Femoral Fractures, Pancreatitis, New Malignancies, Drug-related hypersensitivity reactions, anaphylaxis, rash, urticaria, facial swelling, erythema, severe symptomatic hypocalcemia, Musculoskeletal pain, Parathyroid Hormone (PTH) elevation, Dermatitis, eczema, Severe Bone, Joint, Muscle Pain, Suppression of bone turnover, Abdominal pain upper, Angina pectoris, Anemia, Atrial fibrillation, Back pain, Bone pain, Cataracts, Edema peripheral, Flatulence, Gastroesophageal reflux disease, Herpes zoster, Hypercholesterolemia, Insomnia, Myalgia, Pain in extremity, Pharyngitis, Pneumonia, Pruritus, Rash, Sciatica, Spinal osteoarthritis, Upper respiratory tract infection, Vertigo, death"
309,PROMACTA,all-concat,"hepatic decompensation, hepatotoxicity, thrombotic/thromboembolic complications, cataracts, nausea, diarrhea, upper respiratory tract infection, vomiting, increased ALT, myalgia, urinary tract infection, nasopharyngitis, rhinitis, anemia, pyrexia, fatigue, headache, decreased appetite, influenza-like illness, asthenia, insomnia, cough, pruritus, chills, alopecia, peripheral edema, hemorrhage, oropharyngeal pain, increased AST, pharyngitis, back pain, influenza, paresthesia, rash, musculoskeletal pain, blood alkaline phosphatase increased, dry mouth, hyperbilirubinemia, abdominal pain, toothache, vitamin D deficiency, dyspnea, dizziness, febrile neutropenia, ecchymosis, muscle spasms, arthralgia, rhinorrhea, thrombotic microangiopathy, acute renal failure, ascites, encephalopathy, pain in extremity, transaminases increased, portal vein thrombosis"
310,QUTENZA,all-concat,"Application-Associated Pain, Increase in Blood Pressure, application site erythema, application site pain, application site pruritus, application site papules, application site edema, application site swelling, application site dryness, application site urticaria, application site paresthesia, application site dermatitis, application site hyperesthesia, application site excoriation, application site warmth, application site anesthesia, application site bruising, application site inflammation, application site exfoliation, peripheral edema, nasopharyngitis, bronchitis, sinusitis, nausea, vomiting, pruritus, hypertension, headache, burning sensation, peripheral sensory neuropathy, dizziness, dysgeusia, hyperesthesia, hypoesthesia, cough, throat irritation, abnormal skin odor"
311,SAPHRIS,all-concat,"dementia-related psychosis, Neuroleptic Malignant Syndrome, Tardive Dyskinesia, Metabolic Changes, hypersensitivity reactions, oral ulcers, blisters, peeling/sloughing, inflammation, Orthostatic Hypotension, Syncope, Hemodynamic Effects, Leukopenia, Neutropenia, Agranulocytosis, QT Interval Prolongation, Hyperprolactinemia, seizures, Cognitive Impairment, Motor Impairment, Body Temperature Regulation, Suicide, Dysphagia, increased mortality, application site reactions, Cerebrovascular Adverse Events, stroke, transient ischemic attack, Akathisia, somnolence, oral hypoesthesia, dizziness, extrapyramidal symptoms, increased weight, dysgeusia, oral paresthesia, nausea, increased appetite, fatigue, somnolence, insomnia, irritability, increased weight, increased appetite, hypertension, vomiting, constipation, dry mouth, salivary hypersecretion, stomach discomfort, parkinsonism, tremor, anxiety, depression, arthralgia, pain in extremity, headache, dysmenorrhea, oropharyngeal pain, nasal congestion, dyspnea, rash, Hyperglycemia, Diabetes Mellitus, Dyslipidemia, cholesterol increase, LDL increase, HDL decrease, triglycerides increase, Weight Gain, hypersensitivity reactions, anaphylaxis, angioedema, tachycardia, swollen tongue, wheezing, hypotension, bradycardia, respiratory depression, central nervous system depression, gynecomastia, amenorrhea, galactorrhea, anemia, thrombocytopenia, temporary bundle branch block, accommodation disorder, swollen tongue, idiosyncratic drug reaction, hyponatremia, dysarthria, diplopia, blurred vision, gastroesophageal reflux disease, fall, photosensitivity reaction, enuresis, choking, oropharyngeal muscular dysfunction, hyperpyrexia, autonomic instability, altered mental status, myoglobinuria, rhabdomyolysis, acute renal failure, hypokalemia, hypomagnesemia, pyrexia, dehydration, aspiration pneumonia, death"
312,SIMPONI,all-concat,"Serious Infections, Malignancies, Upper Respiratory Tract Infection, Viral Infection, Bronchitis, Hypertension, Rash, Sepsis, Pneumonia, Cellulitis, Abscess, Opportunistic Infections, Tuberculosis (TB), Invasive Fungal Infections, Liver Enzyme Elevations, Acute Liver Failure, Autoimmune Disorders, Lupus-like syndrome, Anti-dsDNA Antibodies, Administration Reactions, Infusion Reaction, Immunogenicity, Antibodies to SIMPONI ARIA, Neutralizing Antibodies, Neoplasm Benign, Melanoma, Immune System Disorders, Serious Systemic Hypersensitivity Reactions, Anaphylactic Reaction, Sarcoidosis, Respiratory, Thoracic and Mediastinal Disorders, Interstitial Lung Disease, Skin and Subcutaneous Tissue Disorders, Skin Exfoliation, Bullous Skin Reactions, Hepatitis B Reactivation, Congestive Heart Failure, Demyelinating Disorders, Multiple Sclerosis (MS), Guillain-Barre Syndrome, Central Demyelination, Optic Neuritis, Peripheral Demyelinating Polyneuropathy, Hematologic Cytopenias, Pancytopenia, Leukopenia, Neutropenia, Aplastic Anemia, Thrombocytopenia, Vaccinations (Live Vaccines), Therapeutic Infectious Agents, BCG Bladder Instillation, Death."
313,SIRTURO,all-concat,"Increased mortality, death, QT Prolongation, Hepatotoxicity, Drug Interactions, Nausea, Arthralgia, Headache, Hemoptysis, Chest Pain, Anorexia, Transaminases Increased, Rash, Blood Amylase Increased, Aminotransferase elevations, Alanine aminotransferase or aspartate aminotransferase increased, Clinically significant ventricular arrhythmia, Dark urine, Liver tenderness, Hepatomegaly, Fatigue, Jaundice, ALT elevation, AST elevation, Alkaline phosphatase elevation, Bilirubin elevation, Syncope, Aminotransferase elevation with total bilirubin greater than two times the upper limit of normal, Aminotransferase elevation greater than eight times the upper limit of normal, Aminotransferase elevation greater than five times the upper limit of normal and persist beyond two weeks"
314,STENDRA,all-concat,"headache, flushing, nasal congestion, nasopharyngitis, back pain, upper respiratory infection (URI), bronchitis, influenza, sinusitis, sinus congestion, hypertension, dyspepsia, nausea, constipation, rash, edema peripheral, fatigue, angina, unstable angina, deep vein thrombosis, palpitations, gastritis, gastroesophageal reflux disease, hypoglycemia, blood glucose increased, alanine aminotransferase increased, oropharyngeal pain, stomach discomfort, vomiting, muscle spasms, musculoskeletal pain, myalgia, pain in extremity, depression, insomnia, somnolence, vertigo, cough, dyspnea exertional, epistaxis, wheezing, pruritus, balanitis, erection increased, hematuria, nephrolithiasis, pollakiuria, urinary tract infection, Non-arteritic anterior ischemic optic neuropathy (NAION), priapism, electrocardiogram abnormal, dizziness, arthralgia, diarrhea, gastroenteritis viral, tinnitus, decrease in vision, loss of vision, penile tissue damage, loss of potency, anatomical deformation of the penis, angulation, cavernosal fibrosis, Peyronie's disease, sickle cell anemia, multiple myeloma, leukemia, sudden decrease or loss of hearing, orthostatic signs and symptoms, increase in heart rate, decrease in standing blood pressure, anti-aggregatory effect, STI protection, death"
315,STRIBILD,all-concat,"Lactic Acidosis, Severe Hepatomegaly with Steatosis, Severe Acute Exacerbations of Hepatitis B, New Onset or Worsening Renal Impairment, Bone Effects of Tenofovir DF, Immune Reconstitution Syndrome, nausea, diarrhea, ocular icterus, flatulence, fatigue, jaundice, somnolence, headache, dizziness, insomnia, abnormal dreams, rash, suicidal ideation, suicide attempt, depression, abdominal pain, dyspepsia, vomiting, fever, pain, nasopharyngitis, pneumonia, sinusitis, upper respiratory tract infection, arthralgia, back pain, myalgia, paresthesia, peripheral neuropathy, peripheral neuritis, neuropathy, anxiety, increased cough, rhinitis, hyperpigmentation, allergic reaction, angioedema, hypokalemia, hypophosphatemia, dyspnea, pancreatitis, hepatic steatosis, hepatitis, increased liver enzymes, AST, ALT, gamma GT, rhabdomyolysis, osteomalacia, muscular weakness, myopathy, acute renal failure, renal failure, acute tubular necrosis, Fanconi syndrome, proximal renal tubulopathy, interstitial nephritis, nephrogenic diabetes insipidus, renal insufficiency, proteinuria, polyuria, asthenia, death"
316,TAFINLAR,all-concat,"new primary malignancies, tumor promotion, hemorrhage, venous thromboembolism, cardiomyopathy, ocular toxicities, serious febrile reactions, serious skin toxicity, hyperglycemia, glucose-6-phosphate dehydrogenase deficiency, embryofetal toxicity, cutaneous squamous cell carcinoma, keratoacanthoma, melanoma, basal cell carcinoma, non-cutaneous malignancies, deep vein thrombosis, pulmonary embolism, LVEF decrease, uveitis, iritis, fever, hypotension, rigors, chills, dehydration, renal failure, rash, secondary skin infections, vision blurred, transient blindness, stomatitis, pancreatitis, asthenia, cellulitis, folliculitis, paronychia, rash pustular, skin papilloma, palmar-plantar erythrodysesthesia syndrome, hyperkeratosis, hyperhidrosis, hypertension, leukopenia, lymphopenia, neutropenia, anemia, thrombocytopenia, increased aspartate aminotransferase, increased alkaline phosphatase, increased alanine aminotransferase, hyperbilirubinemia, hyperglycemia, increased gamma-glutamyltransferase, hyponatremia, hypoalbuminemia, hypophosphatemia, hypokalemia, increased creatinine, hypomagnesemia, hyperkalemia, hypercalcemia, hypocalcemia, QT prolongation, retinal vein occlusion, interstitial lung disease, death"
317,TANZEUM,all-concat,"Risk of Thyroid C-cell Tumors, Acute Pancreatitis, Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin, Hypersensitivity Reactions, Renal Impairment, upper respiratory tract infection, diarrhea, nausea, injection site reaction, cough, back pain, arthralgia, sinusitis, influenza, vomiting, gastroesophageal reflux disease, dyspepsia, constipation, injection site hematoma, injection site erythema, injection site rash, injection site hypersensitivity, injection site hemorrhage, injection site pruritus, pneumonia, atrial fibrillation, atrial flutter, appendicitis, immunogenicity, anti-albiglutide antibodies, anti-GLP-1 antibodies, Liver Enzyme Abnormalities, alanine aminotransferase (ALT) increase, Gamma Glutamyltransferase (GGT) Increase, Heart Rate Increase"
318,TECFIDERA,all-concat,"anaphylaxis, angioedema, progressive multifocal leukoencephalopathy, PML, lymphopenia, flushing, abdominal pain, diarrhea, nausea, vomiting, pruritus, rash, albumin urine present, erythema, dyspepsia, aspartate aminotransferase increased, hepatic transaminases elevation, alanine aminotransferase increased, eosinophilia, difficulty breathing, urticaria, swelling of the throat, swelling of the tongue, death"
319,TEFLARO,all-concat,"Hypersensitivity Reactions, Clostridium difficile-Associated diarrhea, Direct Coombs' Test Seroconversion, diarrhea, nausea, rash, constipation, vomiting, increased transaminases, hypokalemia, phlebitis, anemia, eosinophilia, neutropenia, thrombocytopenia, bradycardia, palpitations, abdominal pain, pyrexia, hepatitis, anaphylaxis, Clostridium difficile colitis, hyperglycemia, hyperkalemia, dizziness, convulsion, renal failure, urticaria, agranulocytosis, death"
320,TIVICAY,all-concat,"hypersensitivity reactions, serum liver biochemistries elevation, hepatitis B or C co-infection, fat redistribution, immune reconstitution syndrome, insomnia, fatigue, headache, treatment-emergent adverse drug reactions, ADRs, treatment-naive subjects, adverse events leading to discontinuation, depression, abnormal dreams, dizziness, nausea, diarrhea, rash, vertigo, abdominal pain, abdominal discomfort, flatulence, upper abdominal pain, vomiting, hepatitis, myositis, suicidal ideation, suicidal attempt, suicidal behavior, death, renal impairment, pruritus, laboratory abnormalities, ALT elevation, AST elevation, creatine kinase elevation, hyperglycemia, lipase elevation, total neutrophils abnormalities, cholesterol elevation, HDL cholesterol increase, LDL cholesterol increase, triglycerides increase, elevated ALT, elevated AST, elevated cholesterol, elevated creatine kinase, hyperglycemia, elevated lipase, Grade 3 to 4 treatment-emergent hematology laboratory abnormality, neutropenia, worsening or development of transaminase elevations, hepatotoxicity, redistribution-accumulation of body fat, central obesity, dorsocervical fat enlargement, peripheral wasting, facial wasting, breast enlargement, ""cushingoid appearance"", inflammatory response to opportunistic infections, Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia, tuberculosis, autoimmune disorders, Graves' disease, polymyositis, Guillain-Barre syndrome."
321,TOVIAZ,all-concat,"dry mouth, constipation, dyspepsia, nausea, abdominal pain upper, urinary tract infection, upper respiratory tract infection, dry eyes, dysuria, urinary retention, cough, dry throat, edema peripheral, back pain, insomnia, ALT increased, GGT increased, rash, blurred vision, palpitations, hypersensitivity reactions, angioedema with airway obstruction, face edema, dizziness, headache, somnolence, urticaria, pruritus, angina, chest pain, gastroenteritis, QT prolongation on ECG, diverticulitis, irritable bowel syndrome, electrocardiogram QT corrected interval prolongation, death"
322,TREANDA,all-concat,"myelosuppression, infections, anaphylaxis, infusion reactions, tumor lysis syndrome, skin reactions, other malignancies, extravasation injury, pyrexia, nausea, vomiting, fatigue, diarrhea, constipation, anorexia, cough, headache, weight decreased, dyspnea, rash, stomatitis, lymphopenia, anemia, leukopenia, thrombocytopenia, neutropenia, asthenia, malaise, weakness, dry mouth, somnolence, mucosal inflammation, worsening hypertension, hypertensive crisis, hypersensitivity, gastrointestinal disorders, generalized disorders and administration site conditions, immune system disorders, infections and infestations, investigations, metabolism and nutrition disorders, respiratory, thoracic and mediastinal disorders, skin and subcutaneous tissue disorders, hematologic abnormalities, bilirubin elevations, increased AST, increased ALT, changes in creatinine levels, cardiac disorders, gastrointestinal disturbances, pyrexia, chills, edema peripheral, infusion site pain, catheter site pain, herpes zoster, urinary tract infection, sinusitis, febrile neutropenia, oral candidiasis, musculoskeletal and connective tissue disorders, nervous system disorders, psychiatric disorders, dry skin, night sweats, hyperhidrosis, vascular disorders, hemolysis, dysgeusia, taste disorder, atypical pneumonia, sepsis, herpes zoster, erythema, dermatitis, skin necrosis, anaphylaxis, drug-related adverse reactions, phlebitis, pruritus, pain, swelling, pneumocystis jiroveci pneumonia, pneumonitis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), acute renal failure, cardiac failure, pulmonary fibrosis, myelodysplastic syndrome, neutropenic sepsis, diffuse alveolar hemorrhage, opportunistic infection (CMV), septicaemic shock, hypersensitivity, renal failure, acute renal failure, hyperglycemia, elevated creatinine, hyponatremia, hypocalcemia, embryo-fetal toxicity, fetal harm, resorptions, skeletal malformations, visceral malformations, decreased fetal body weights, death."
323,TRULICITY,all-concat,"Thyroid C-cell Tumors, Pancreatitis, Hypoglycemia, Hypersensitivity reactions, Renal impairment, Severe Gastrointestinal Disease, Nausea, Diarrhea, Vomiting, Abdominal Pain, Decreased Appetite, Dyspepsia, Fatigue, Asthenia, Malaise, Constipation, Flatulence, Abdominal distension, Gastroesophageal reflux disease, Eructation, Sinus Tachycardia, Heart Rate Increase, Immunogenicity, Anti-drug antibodies (ADAs), Dulaglutide-neutralizing antibodies, Systemic hypersensitivity, Severe urticaria, Systemic rash, Facial edema, Lip swelling, Injection-site reactions, Injection-site rash, Erythema, PR Interval Prolongation, First Degree Atrioventricular (AV) Block, Amylase Increase, Lipase Increase, Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), Documented symptomatic hypoglycemia, Severe hypoglycemia, Gastrointestinal Adverse Reactions, Mild Gastrointestinal reactions, Moderate Gastrointestinal reactions, Severe Gastrointestinal reactions, Severe abdominal pain, Dehydration, Gastroparesis"
324,TUDORZA,all-concat,"paradoxical bronchospasm, worsening of narrow-angle glaucoma, worsening of urinary retention, immediate hypersensitivity reactions, anaphylaxis, angioedema, urticaria, rash, bronchospasm, itching, headache, nasopharyngitis, cough, diarrhea, sinusitis, rhinitis, toothache, fall, vomiting, diabetes mellitus, dry mouth, 1st degree AV block, osteoarthritis, cardiac failure, cardio-respiratory arrest, death"
325,ULESFIA,all-concat,"ocular irritation, application site irritation, application site anesthesia, hypoesthesia, skin irritation, scalp irritation, application site dryness, application site excoriation, paraesthesia, application site dermatitis, excoriation, thermal burn, dandruff, erythema, rash, skin exfoliation, pruritus, pyoderma, pain, eye irritation, contact dermatitis, gasping syndrome, severe metabolic acidosis, gasping respirations, progressive hypotension, seizures, central nervous system depression, intraventricular hemorrhage, death"
326,ULORIC,all-concat,"liver function abnormalities, nausea, arthralgia, rash, dizziness, anemia, idiopathic thrombocytopenic purpura, leukocytosis, leukopenia, neutropenia, pancytopenia, splenomegaly, thrombocytopenia, angina pectoris, atrial fibrillation/flutter, cardiac murmur, ECG abnormal, palpitations, sinus bradycardia, tachycardia, deafness, tinnitus, vertigo, vision blurred, abdominal distention, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, frequent stools, gastritis, gastroesophageal reflux disease, gastrointestinal discomfort, gingival pain, haematemesis, hyperchlorhydria, hematochezia, mouth ulceration, pancreatitis, peptic ulcer, vomiting, asthenia, chest pain/discomfort, edema, fatigue, feeling abnormal, gait disturbance, influenza-like symptoms, mass, pain, thirst, cholelithiasis, cholecystitis, hepatic steatosis, hepatitis, hepatomegaly, hypersensitivity, herpes zoster, contusion, anorexia, appetite decreased/increased, dehydration, diabetes mellitus, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hypokalemia, weight decreased/increased, arthritis, joint stiffness, joint swelling, muscle spasms, muscle twitching, muscle tightness, muscle weakness, musculoskeletal pain, musculoskeletal stiffness, myalgia, altered taste, balance disorder, cerebrovascular accident, Guillain-Barre syndrome, headache, hemiparesis, hypoesthesia, hyposmia, lacunar infarction, lethargy, mental impairment, migraine, paresthesia, somnolence, transient ischemic attack, tremor, agitation, anxiety, depression, insomnia, irritability, libido decreased, nervousness, panic attack, personality change, hematuria, nephrolithiasis, pollakiuria, proteinuria, renal failure, renal insufficiency, urgency, incontinence, breast pain, erectile dysfunction, gynecomastia, bronchitis, cough, dyspnea, epistaxis, nasal dryness, paranasal sinus hypersecretion, pharyngeal edema, respiratory tract congestion, sneezing, throat irritation, upper respiratory tract infection, alopecia, angio-edema, dermatitis, dermographism, ecchymosis, eczema, hair color changes, hair growth abnormal, hyperhidrosis, peeling skin, petechiae, photosensitivity, pruritus, purpura, skin discoloration, altered pigmentation, skin lesion, skin odor abnormal, urticaria, flushing, hot flush, hypertension, hypotension, activated partial thromboplastin time prolonged, creatine increased, bicarbonate decreased, sodium increased, EEG abnormal, glucose increased, cholesterol increased, triglycerides increased, amylase increased, potassium increased, TSH increased, platelet count decreased, hematocrit decreased, hemoglobin decreased, MCV increased, RBC decreased, creatinine increased, blood urea increased, BUN/creatinine ratio increased, creatine phosphokinase (CPK) increased, alkaline phosphatase increased, LDH increased, PSA increased, urine output increased/decreased, lymphocyte count decreased, neutrophil count decreased, WBC increased/decreased, coagulation test abnormal, low density lipoprotein (LDL) increased, prothrombin time prolonged, urinary casts, urine positive for white blood cells and protein, hepatic failure, jaundice, liver disorder, anaphylaxis, anaphylactic reaction, rhabdomyolysis, psychotic behavior including aggressive thoughts, tubulointerstitial nephritis, generalized rash, Stevens-Johnson Syndrome, cardiovascular thromboembolic events, death."
327,VICTRELIS,all-concat,"fatigue, anemia, nausea, headache, dysgeusia, neutropenia, pancytopenia, hypersensitivity, embryofetal toxicity, decreased appetite, arthralgia, dizziness, insomnia, irritability, chills, asthenia, exertional dyspnea, dry mouth, vomiting, diarrhea, alopecia, dry skin, rash, mouth ulceration, stomatitis, pneumonia, sepsis, agranulocytosis, thrombocytopenia, angioedema, urticaria, drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, exfoliative rash, exfoliative dermatitis, Stevens-Johnson syndrome, toxic skin eruption, toxicoderma, death"
328,VIMIZIM,all-concat,"anaphylaxis, hypersensitivity reactions, pyrexia, vomiting, headache, nausea, abdominal pain, chills, fatigue, cough, erythema, throat tightness, urticaria, flushing, cyanosis, hypotension, rash, dyspnea, chest discomfort, gastrointestinal symptoms, retching, peripheral edema, sleep apnea, spinal or cervical cord compression (SCC), back pain, paralysis, urinary incontinence, fecal incontinence, death"
329,VIZAMYL,all-concat,"flushing, headache, increased blood pressure, nausea, dizziness, serious hypersensitivity reaction, dyspnea, chest pressure, death, hypersensitivity reactions, image interpretation errors, radiation risk"
330,VORAXAZE,all-concat,"serious allergic reactions, anaphylactic reactions, paraesthesias, flushing, feeling hot, burning sensation, nausea and/or vomiting, hypotension, headache, blurred vision, diarrhea, hypersensitivity, hypertension, rash, throat irritation, throat tightness, tremor, death"
331,XALKORI,all-concat,"hepatotoxicity, Interstitial Lung Disease, Pneumonitis, QT Interval Prolongation, Bradycardia, Severe Visual Loss, vision disorders, diarrhea, nausea, vomiting, constipation, edema, elevated transaminases, upper respiratory infection, decreased appetite, dysgeusia, dyspnea, pulmonary embolism, septic shock, acute respiratory failure, diabetic ketoacidosis, death, dose reductions, dose reduction, permanent discontinuation, vision disorder, Vision impairment, photopsia, blurred vision, vitreous floaters, neuropathy, Renal cysts, Visual Symptom Assessment Questionnaire, VSAQ-ALK, sensory neuropathy, rash, hepatic failure, Hematology, Neutropenia, Lymphopenia, Chemistry, ALT elevation, AST elevation, Hypophosphatemia, acute respiratory distress syndrome, arrhythmia, respiratory failure, sepsis, Hypokalemia, Syncope, weight decreased, weight increased, pain in extremity, muscle spasm, dizziness, headache, pyrexia, abdominal pain, dysphagia, dyspepsia, Electrocadiogram QT prolonged, Electrolyte abnormalities, Drug-induced hepatotoxicity, Congenital long QT syndrome, Torsade de pointes, polymorphic ventricular tachycardia, serious arrhythmia, Symptomatic bradycardia, Optic atrophy, optic nerve disorder, vision loss, Visual field defect, best corrected visual acuity, retinal photographs, visual fields, optical coherence tomography, embryotoxicity, fetotoxicity"
332,XEOMIN,all-concat,"hypersensitivity, dysphagia, breathing difficulties, spread of effects from toxin, neck pain, muscle weakness, injection site pain, musculoskeletal pain, eyelid ptosis, dry eye, dry mouth, diarrhea, headache, visual impairment, dyspnea, nasopharyngitis, respiratory tract infection, facial paresis, injection site hematoma, eyelid edema, eye swelling, nausea, flu-like symptoms, injection site reaction, allergic dermatitis, localized allergic reactions, swelling, edema, erythema, pruritus, rash, herpes zoster, muscular weakness, muscle spasm, dysarthria, myalgia, asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphonia, urinary incontinence, asthenia, death"
333,XIAFLEX,all-concat,"tendon ruptures, serious injury, injected extremity, corporal rupture, penile fracture, severe penile hematoma, penile ecchymoses, hematoma, sudden penile detumescence, penile ""popping"" sound, penile ""popping"" sensation, edema peripheral, swelling of the injected hand, contusion, injection site hemorrhage, injection site reaction, pain in the treated extremity, penile swelling, penile pain, pruritus, lymphadenopathy, skin laceration, lymph node pain, erythema, axillary pain, vasovagal syncope, finger extension procedures, flexor tendon rupture, pulley rupture, ligament injury, complex regional pain syndrome (CRPS), sensory abnormality of the hand, tear, blood blister, injection site hematoma, injection site swelling, ecchymosis, blood blister, pruritus genital, painful erection, erectile dysfunction, skin discoloration, procedural pain, injection site vesicles, localized edema, dyspareunia, injection site pruritus, nodule, suprapubic pain, severe injection site hematoma, penile ""popping"" sounds, penile ""popping"" sensations, snapping, cracking, anaphylaxis, severe allergic reactions, IgE-anti-drug antibodies, ecchymosis, coagulation disorders."
334,XTANDI,all-concat,"Seizure, asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased, headache, hypertension, dizziness/vertigo, muscular weakness, musculoskeletal stiffness, spinal cord compression, cauda equina syndrome, paresthesia, mental impairment disorders, hypoesthesia, lower respiratory tract and lung infection, insomnia, anxiety, hematuria, pollakiuria, fall, non-pathologic fractures, pruritus, dry skin, epistaxis, dysgeusia, restless legs syndrome, gynecomastia, neutropenia, thrombocytopenia, ALT elevations, bilirubin elevations, falls including fall-related injuries, hypertensive crisis, seizure-related discontinuation, death"
335,YERVOY,all-concat,"immune-mediated enterocolitis, immune-mediated hepatitis, immune-mediated dermatitis, immune-mediated neuropathies, immune-mediated endocrinopathies, ocular manifestations, fatigue, diarrhea, pruritus, rash, colitis, severe, life-threatening, death, intestinal perforation, hepatotoxicity, Dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, rash complicated by full thickness dermal ulceration, necrotic manifestations, bullous manifestations, hemorrhagic manifestations, moderate dermatitis, severe dermatitis, Guillain-Barre syndrome, peripheral motor neuropathy, myasthenia gravis, hypopituitarism, adrenal insufficiency, hypogonadism, hypothyroidism, hyperthyroidism, Cushing's syndrome, hypophysitis, nephritis, pneumonitis, meningitis, pericarditis, uveitis, iritis, hemolytic anemia, myocarditis, angiopathy, temporal arteritis, vasculitis, polymyalgia rheumatica, conjunctivitis, blepharitis, episcleritis, scleritis, leukocytoclastic vasculitis, erythema multiforme, psoriasis, pancreatitis, arthritis, autoimmune thyroiditis, sarcoidosis, neurosensory hypoacusis, autoimmune central neuropathy, encephalitis, myositis, polymyositis, ocular myositis, Large intestinal ulcer, esophagitis, acute respiratory distress syndrome, renal failure, infusion reaction, hypogonadism, Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome)"
336,ZERBAXA,all-concat,"hypersensitivity reactions, Clostridium difficile-associated diarrhea, nausea, diarrhea, headache, pyrexia, constipation, insomnia, vomiting, hypokalemia, ALT increased, AST increased, anemia, thrombocytosis, abdominal pain, anxiety, dizziness, hypotension, atrial fibrillation, rash, renal impairment, renal failure, death, cardiac disorders, tachycardia, angina pectoris, gastrointestinal disorders, ileus, gastritis, abdominal distension, dyspepsia, flatulence, ileus paralytic, general disorders and administration site conditions, infusion site reactions, infections and infestations, candidiasis, oropharyngeal, fungal urinary tract infection, investigations, increased serum gamma-glutamyl transpeptidase (GGT), increased serum alkaline phosphatase, positive Coombs test, metabolism and nutrition disorders, hyperglycemia, hypomagnesemia, hypophosphatemia, nervous system disorders, ischemic stroke, respiratory, thoracic and mediastinal disorders, dyspnea, skin and subcutaneous tissue disorders, urticaria, vascular disorders, venous thrombosis."
337,ZYDELIG,all-concat,"hepatotoxicity, severe diarrhea, colitis, pneumonitis, intestinal perforation, severe cutaneous reactions, anaphylaxis, neutropenia, diarrhea, pyrexia, fatigue, nausea, cough, pneumonia, abdominal pain, chills, rash, hypertriglyceridemia, hyperglycemia, ALT elevations, AST elevations, vomiting, gastroesophageal reflux disease, stomatitis, headache, pain, nasal congestion, sepsis, bronchitis, sinusitis, urinary tract infection, arthralgia, lymphocyte count decreased, lymphocyte count increased, GGT increased, hypoglycemia, hyponatremia, asthenia, peripheral edema, upper respiratory tract infection, dyspnea, night sweats, decreased appetite, insomnia, hemoglobin decreased, platelets decreased, death"
338,ZYKADIA,all-concat,"Severe or Persistent Gastrointestinal Toxicity, Hepatotoxicity, Interstitial Lung Disease/Pneumonitis, QT Interval Prolongation, Hyperglycemia, Bradycardia, Pancreatitis, Embryofetal Toxicity, diarrhea, nausea, elevated transaminases, vomiting, abdominal pain, fatigue, decreased appetite, constipation, convulsion, pneumonia, dyspnea, dehydration, respiratory failure, pneumothorax, gastric hemorrhage, general physical health deterioration, pulmonary tuberculosis, cardiac tamponade, sepsis, neuropathy (comprised of paresthesia, muscular weakness, gait disturbance, peripheral neuropathy, hypoesthesia, peripheral sensory neuropathy, dysesthesia, neuralgia, peripheral motor neuropathy, hypotonia, polyneuropathy), vision disorder (comprised of vision impairment, blurred vision, photopsia, accommodation disorder, presbyopia, reduced visual acuity), prolonged QT interval, Hemoglobin decreased, Alanine transaminase (ALT) increased, Aspartate transaminase (AST) increased, Creatinine increased, Glucose increased, Phosphate decreased, Lipase increased, Bilirubin (total) increased, death"
339,ZYTIGA,all-concat,"fatigue, joint swelling or discomfort, edema, hot flush, diarrhea, vomiting, cough, hypertension, dyspnea, urinary tract infection, contusion, anemia, elevated alkaline phosphatase, hypertriglyceridemia, lymphopenia, hypercholesterolemia, hyperglycemia, elevated AST, hypophosphatemia, elevated ALT, hypokalemia, muscle discomfort, dyspepsia, upper respiratory tract infection, urinary frequency, nocturia, fractures, arrhythmia, chest pain or chest discomfort, cardiac failure, pyrexia, groin pain, constipation, insomnia, falls, nasopharyngitis, hematuria, rash, non-infectious pneumonitis, myopathy, rhabdomyolysis, hypernatremia, adrenocortical insufficiency, hepatotoxicity, myocardial ischemia, myocardial infarction, cardiorespiratory arrest, cardiac disorders, death"
